Upload
others
View
2
Download
0
Embed Size (px)
Citation preview
1
Preventing Opioid Overdose with
Education and Naloxone Rescue Kits
Alexander Y Walley MD MSc Boston University School of Medicine Boston Medical Center
Association for Medical Education and Research in Substance Abuse (AMERSA)
Alexander Y Walley Disclosures
2
bull No financial relationships to disclose
The contents of this activity may include discussion of off label or investigative drug uses The
faculty is aware that is their responsibility to disclose this information
Target Audience
3
bull The overarching goal of PCSS-MAT is to make
available the most effective medication-assisted
treatments to serve patients in a variety of settings
including primary care psychiatric care and pain
management settings
Educational Objectives
4
bull At the conclusion of this activity participants should
be able to
Review the epidemiology of opioid overdose
Describe the rationale for and scope of overdose education
and naloxone distribution (OEND) programs
Implement OEND in settings that offer medication for opioid
use disorder
ndash Educate patients about overdose risk reduction
ndash Prescribe naloxone rescue kits
Case 29 yo woman presents to
clinic for buprenorphine treatment
5
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12 step program
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman on
buprenorphine treatment
6
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine toxicology only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
7
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine toxicology only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Hospitalized in intensive care for overdose
Her boyfriend was released from jail and returned to stay with her
He relapsed and overdosed on heroin on the 3rd night ndash likely fentanyl
minus Packed his underwear with ice tried to rescue breathe but did not
respond so she called 911 and they were unable to save him
minus Child protection was notified about the incident and they removed
her son from the home
She stopped buprenorphine started drinking alcohol then relapsed
to heroinfentanyl and overdosed
Case 29 yo woman on
buprenorphine treatment
8
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine toxicology only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Hospitalized in intensive care for overdose
Her boyfriend was released from jail and returned to stay with her
He relapsed and overdosed on heroin on the 3rd night ndash likely fentanyl
minus Packed his underwear with ice tried to rescue breathe but did not
respond so she called 911 and they were unable to save him
minus Child protection was notified about the incident and they removed
her son from the home
She stopped buprenorphine started drinking alcohol then relapsed
to heroinfentanyl and overdosed
How could overdose prevention improve this case
Overdose continues to increase and is the
leading cause of accidental injury death
10
Rates of Drug Overdose Deaths
by State Change from 2010 to 2015
Rudd et al 2016
bull Opioid death rates increased by 156 from 2014 to 2015
bull Increase driven by synthetic opioids (illicitly-manufactured fentanyl and heroin)
bull Increases in these opioid subcategories occurred overall and across all demographics and regions
Alpert A Powell D Pacula RL Supply-Side Drug Policy in the
Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic
Research 2017 Jan 5
Overdose deaths since
2010 are driven by
heroin and fentanyl
not prescription opioids
Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three
Years NYT ndash The UpShot 922017
Fentanyl is Driving Overdose Surge
12
13
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
14
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
15
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
16
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
17
Boston Globe ndash December 27 2015
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
18
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
Public health response to address overdoses related to illicitly made fentanyl
1 Fentanyl should be included on standard toxicology screens
2 Adapt existing harm reduction strategies such as direct observation of anyone using illicit
opioids and ensuring bystanders are equipped with naloxone
3 Enhanced access and linkage to medication for opioid use disorders
ldquoSo now what they [people selling illicit drugs] are doing is theyrsquore cutting the heroin with the fentanyl to make it stronger
And the dope [heroin] is so strong with the fentanyl in it that you get the whole dose of the fentanyl at once rather than
being time-released [like the patch] And thatrsquos why people are dyingmdashplain and simple You know they [people using
illicit drugs] are doing the whole bag [of heroin mixed with fentanyl] and they donrsquot realize that they canrsquot handle it their
body cant handle itrdquo -- Overdose bystander
Strategies to Address Fentanyl
Overdose Deaths
19
ldquoThe AMA has been a longtime supporter of increasing the availability of Naloxone for patients first responders and bystanders who can help save lives and has provided resources to bolster legislative efforts to increase access to this medication in several statesrdquo
wwwama-assnorgamapubnewsnews20142014-04-
07-naxolene-product-approvalpage
ldquoAPhA supports the pharmacistrsquos
role in selecting appropriate therapy
and dosing and initiating and
providing education about the
proper use of opioid reversal
agents to prevent opioid-related
deaths due to overdoserdquo
wwwpharmacistcompolicycontrolled-substances-and-
other-medications-potential-abuse-and-use-opioid-
reversal-agents-2
Overdose education and naloxone distribution is
a key tool in addressing the overdose crisis
ASAM Board of Directors April 2010
ldquoNaloxone has been proven to be an effective fast-acting inexpensive and non-addictive opioid antagonist with minimal side effects Naloxone can be administered quickly and effectively by trained professional and lay individuals who observe the initial signs of an opioid overdose reactionrdquo
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
Naloxone Basics
21
Patients can go back into overdose if long acting opioids were taken
(fentanyl patch methadone extended release morphine extended release oxycodone)
Patients should avoid taking more opioids after naloxone administration so they do not go back into overdose after naloxone wears off
Patients may want to take more opioids during this time because they may feel withdrawal symptoms
Wears off in 30 - 90 minutes
Store at room temperature to minimize degradation
Shelf-life is 12-24 months
If patient is not responding in this time a second dose may need be administered
Takes effect in 2 - 3 minutes
21
Naloxone Formulations
Intranasal with atomizer attachment Auto-Injector
Intranasal spray Intramuscular injection
Rationale for Overdose Education
and Naloxone Rescue Kits bull Most people who use opioids do not use
alone
bull Known risk factors
Mixing substances loss of opioid
tolerance using alone unknown
source
bull Opportunity window
Opioid overdoses take minutes to hours
and is reversible with naloxone
Fentanyl reduces the window to seconds
to minutes
bull Bystanders are trainable to
recognize and respond to overdoses
bull Fear of public safety 23
Evaluations of Overdose Education and Naloxone Distribution Programs
24
Feasibility
bull Piper et al Subst Use Misuse 2008 43 858-70 bull Doe-Simkins et al Am J Public Health 2009 99 788-791 bull Enteen et al J Urban Health 201087 931-41 bull Bennett et al J Urban Health 2011 88 1020-30 bull Walley et al JSAT 2013 44241-7 (Methadone and detox programs)
Increased knowledge and skills
bull Green et al Addiction 2008 103979-89 bull Tobin et al Int J Drug Policy 2009 20 131-6 bull Wagner et al Int J Drug Policy 2010 21 186-93
No increase in use increase in drug
treatment
bull Seal et al J Urban Health 200582303-11 bull Doe-Simkins et al BMC Public Health 2014 14297 bull Jones et al Addictive Behaviors 201771104-6
Reduction in overdose in communities
bull Maxwell et al J Addict Dis 200625 89-96 bull Evans et al Am J Epidemiol 2012 174 302-8 bull Walley et al BMJ 2013 346 f174 bull Bird et al Addiction 2015 Dec 1 bull Coffin et al Ann Intern Med 2016 1-8
Cost-effective
$438 (best) to $14000 (worst ) per quality-
adjusted life year gained
bull Coffin and Sullivan Ann Intern Med 2013 Jan 1158(1)1-9
25
Objective Determine the impact of
opioid overdose education with
intranasal naloxone distribution
(OEND) programs on fatal and non-
fatal opioid overdose rates in
Massachusetts
Walley et al BMJ 2013 346 f174
INPEDE OD (Intranasal Naloxone and Prevention Educationrsquos Effect on
Overdose Study)
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
26
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
OEND programs 2006-07
27
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
28
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
29
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
Towns without
30
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
Fatal Opioid Overdose Rates by
OEND Implementation
31
Cumulative enrollments per 100k RR ARR 95 CI
Absolute model
No enrollment Ref Ref Ref
Low implementation 1-100 093 073 057-091
High implementation gt 100 082 054 039-076
Adjusted Rate Ratios (ARR) All rate ratios adjusted for the citytown
population rates of age under 18 male race ethnicity (hispanic white black other) below poverty level medically supervised
inpatient withdrawal treatment methadone treatment BSAS-funded buprenorphine treatment prescriptions to doctor shoppers and
year
Walley et al BMJ 2013 346 f174
Naloxone coverage per 100K
0
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
Opioid overdose death rate
27 reduction
32
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Alexander Y Walley Disclosures
2
bull No financial relationships to disclose
The contents of this activity may include discussion of off label or investigative drug uses The
faculty is aware that is their responsibility to disclose this information
Target Audience
3
bull The overarching goal of PCSS-MAT is to make
available the most effective medication-assisted
treatments to serve patients in a variety of settings
including primary care psychiatric care and pain
management settings
Educational Objectives
4
bull At the conclusion of this activity participants should
be able to
Review the epidemiology of opioid overdose
Describe the rationale for and scope of overdose education
and naloxone distribution (OEND) programs
Implement OEND in settings that offer medication for opioid
use disorder
ndash Educate patients about overdose risk reduction
ndash Prescribe naloxone rescue kits
Case 29 yo woman presents to
clinic for buprenorphine treatment
5
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12 step program
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman on
buprenorphine treatment
6
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine toxicology only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
7
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine toxicology only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Hospitalized in intensive care for overdose
Her boyfriend was released from jail and returned to stay with her
He relapsed and overdosed on heroin on the 3rd night ndash likely fentanyl
minus Packed his underwear with ice tried to rescue breathe but did not
respond so she called 911 and they were unable to save him
minus Child protection was notified about the incident and they removed
her son from the home
She stopped buprenorphine started drinking alcohol then relapsed
to heroinfentanyl and overdosed
Case 29 yo woman on
buprenorphine treatment
8
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine toxicology only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Hospitalized in intensive care for overdose
Her boyfriend was released from jail and returned to stay with her
He relapsed and overdosed on heroin on the 3rd night ndash likely fentanyl
minus Packed his underwear with ice tried to rescue breathe but did not
respond so she called 911 and they were unable to save him
minus Child protection was notified about the incident and they removed
her son from the home
She stopped buprenorphine started drinking alcohol then relapsed
to heroinfentanyl and overdosed
How could overdose prevention improve this case
Overdose continues to increase and is the
leading cause of accidental injury death
10
Rates of Drug Overdose Deaths
by State Change from 2010 to 2015
Rudd et al 2016
bull Opioid death rates increased by 156 from 2014 to 2015
bull Increase driven by synthetic opioids (illicitly-manufactured fentanyl and heroin)
bull Increases in these opioid subcategories occurred overall and across all demographics and regions
Alpert A Powell D Pacula RL Supply-Side Drug Policy in the
Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic
Research 2017 Jan 5
Overdose deaths since
2010 are driven by
heroin and fentanyl
not prescription opioids
Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three
Years NYT ndash The UpShot 922017
Fentanyl is Driving Overdose Surge
12
13
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
14
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
15
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
16
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
17
Boston Globe ndash December 27 2015
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
18
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
Public health response to address overdoses related to illicitly made fentanyl
1 Fentanyl should be included on standard toxicology screens
2 Adapt existing harm reduction strategies such as direct observation of anyone using illicit
opioids and ensuring bystanders are equipped with naloxone
3 Enhanced access and linkage to medication for opioid use disorders
ldquoSo now what they [people selling illicit drugs] are doing is theyrsquore cutting the heroin with the fentanyl to make it stronger
And the dope [heroin] is so strong with the fentanyl in it that you get the whole dose of the fentanyl at once rather than
being time-released [like the patch] And thatrsquos why people are dyingmdashplain and simple You know they [people using
illicit drugs] are doing the whole bag [of heroin mixed with fentanyl] and they donrsquot realize that they canrsquot handle it their
body cant handle itrdquo -- Overdose bystander
Strategies to Address Fentanyl
Overdose Deaths
19
ldquoThe AMA has been a longtime supporter of increasing the availability of Naloxone for patients first responders and bystanders who can help save lives and has provided resources to bolster legislative efforts to increase access to this medication in several statesrdquo
wwwama-assnorgamapubnewsnews20142014-04-
07-naxolene-product-approvalpage
ldquoAPhA supports the pharmacistrsquos
role in selecting appropriate therapy
and dosing and initiating and
providing education about the
proper use of opioid reversal
agents to prevent opioid-related
deaths due to overdoserdquo
wwwpharmacistcompolicycontrolled-substances-and-
other-medications-potential-abuse-and-use-opioid-
reversal-agents-2
Overdose education and naloxone distribution is
a key tool in addressing the overdose crisis
ASAM Board of Directors April 2010
ldquoNaloxone has been proven to be an effective fast-acting inexpensive and non-addictive opioid antagonist with minimal side effects Naloxone can be administered quickly and effectively by trained professional and lay individuals who observe the initial signs of an opioid overdose reactionrdquo
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
Naloxone Basics
21
Patients can go back into overdose if long acting opioids were taken
(fentanyl patch methadone extended release morphine extended release oxycodone)
Patients should avoid taking more opioids after naloxone administration so they do not go back into overdose after naloxone wears off
Patients may want to take more opioids during this time because they may feel withdrawal symptoms
Wears off in 30 - 90 minutes
Store at room temperature to minimize degradation
Shelf-life is 12-24 months
If patient is not responding in this time a second dose may need be administered
Takes effect in 2 - 3 minutes
21
Naloxone Formulations
Intranasal with atomizer attachment Auto-Injector
Intranasal spray Intramuscular injection
Rationale for Overdose Education
and Naloxone Rescue Kits bull Most people who use opioids do not use
alone
bull Known risk factors
Mixing substances loss of opioid
tolerance using alone unknown
source
bull Opportunity window
Opioid overdoses take minutes to hours
and is reversible with naloxone
Fentanyl reduces the window to seconds
to minutes
bull Bystanders are trainable to
recognize and respond to overdoses
bull Fear of public safety 23
Evaluations of Overdose Education and Naloxone Distribution Programs
24
Feasibility
bull Piper et al Subst Use Misuse 2008 43 858-70 bull Doe-Simkins et al Am J Public Health 2009 99 788-791 bull Enteen et al J Urban Health 201087 931-41 bull Bennett et al J Urban Health 2011 88 1020-30 bull Walley et al JSAT 2013 44241-7 (Methadone and detox programs)
Increased knowledge and skills
bull Green et al Addiction 2008 103979-89 bull Tobin et al Int J Drug Policy 2009 20 131-6 bull Wagner et al Int J Drug Policy 2010 21 186-93
No increase in use increase in drug
treatment
bull Seal et al J Urban Health 200582303-11 bull Doe-Simkins et al BMC Public Health 2014 14297 bull Jones et al Addictive Behaviors 201771104-6
Reduction in overdose in communities
bull Maxwell et al J Addict Dis 200625 89-96 bull Evans et al Am J Epidemiol 2012 174 302-8 bull Walley et al BMJ 2013 346 f174 bull Bird et al Addiction 2015 Dec 1 bull Coffin et al Ann Intern Med 2016 1-8
Cost-effective
$438 (best) to $14000 (worst ) per quality-
adjusted life year gained
bull Coffin and Sullivan Ann Intern Med 2013 Jan 1158(1)1-9
25
Objective Determine the impact of
opioid overdose education with
intranasal naloxone distribution
(OEND) programs on fatal and non-
fatal opioid overdose rates in
Massachusetts
Walley et al BMJ 2013 346 f174
INPEDE OD (Intranasal Naloxone and Prevention Educationrsquos Effect on
Overdose Study)
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
26
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
OEND programs 2006-07
27
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
28
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
29
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
Towns without
30
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
Fatal Opioid Overdose Rates by
OEND Implementation
31
Cumulative enrollments per 100k RR ARR 95 CI
Absolute model
No enrollment Ref Ref Ref
Low implementation 1-100 093 073 057-091
High implementation gt 100 082 054 039-076
Adjusted Rate Ratios (ARR) All rate ratios adjusted for the citytown
population rates of age under 18 male race ethnicity (hispanic white black other) below poverty level medically supervised
inpatient withdrawal treatment methadone treatment BSAS-funded buprenorphine treatment prescriptions to doctor shoppers and
year
Walley et al BMJ 2013 346 f174
Naloxone coverage per 100K
0
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
Opioid overdose death rate
27 reduction
32
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Target Audience
3
bull The overarching goal of PCSS-MAT is to make
available the most effective medication-assisted
treatments to serve patients in a variety of settings
including primary care psychiatric care and pain
management settings
Educational Objectives
4
bull At the conclusion of this activity participants should
be able to
Review the epidemiology of opioid overdose
Describe the rationale for and scope of overdose education
and naloxone distribution (OEND) programs
Implement OEND in settings that offer medication for opioid
use disorder
ndash Educate patients about overdose risk reduction
ndash Prescribe naloxone rescue kits
Case 29 yo woman presents to
clinic for buprenorphine treatment
5
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12 step program
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman on
buprenorphine treatment
6
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine toxicology only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
7
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine toxicology only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Hospitalized in intensive care for overdose
Her boyfriend was released from jail and returned to stay with her
He relapsed and overdosed on heroin on the 3rd night ndash likely fentanyl
minus Packed his underwear with ice tried to rescue breathe but did not
respond so she called 911 and they were unable to save him
minus Child protection was notified about the incident and they removed
her son from the home
She stopped buprenorphine started drinking alcohol then relapsed
to heroinfentanyl and overdosed
Case 29 yo woman on
buprenorphine treatment
8
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine toxicology only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Hospitalized in intensive care for overdose
Her boyfriend was released from jail and returned to stay with her
He relapsed and overdosed on heroin on the 3rd night ndash likely fentanyl
minus Packed his underwear with ice tried to rescue breathe but did not
respond so she called 911 and they were unable to save him
minus Child protection was notified about the incident and they removed
her son from the home
She stopped buprenorphine started drinking alcohol then relapsed
to heroinfentanyl and overdosed
How could overdose prevention improve this case
Overdose continues to increase and is the
leading cause of accidental injury death
10
Rates of Drug Overdose Deaths
by State Change from 2010 to 2015
Rudd et al 2016
bull Opioid death rates increased by 156 from 2014 to 2015
bull Increase driven by synthetic opioids (illicitly-manufactured fentanyl and heroin)
bull Increases in these opioid subcategories occurred overall and across all demographics and regions
Alpert A Powell D Pacula RL Supply-Side Drug Policy in the
Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic
Research 2017 Jan 5
Overdose deaths since
2010 are driven by
heroin and fentanyl
not prescription opioids
Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three
Years NYT ndash The UpShot 922017
Fentanyl is Driving Overdose Surge
12
13
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
14
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
15
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
16
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
17
Boston Globe ndash December 27 2015
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
18
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
Public health response to address overdoses related to illicitly made fentanyl
1 Fentanyl should be included on standard toxicology screens
2 Adapt existing harm reduction strategies such as direct observation of anyone using illicit
opioids and ensuring bystanders are equipped with naloxone
3 Enhanced access and linkage to medication for opioid use disorders
ldquoSo now what they [people selling illicit drugs] are doing is theyrsquore cutting the heroin with the fentanyl to make it stronger
And the dope [heroin] is so strong with the fentanyl in it that you get the whole dose of the fentanyl at once rather than
being time-released [like the patch] And thatrsquos why people are dyingmdashplain and simple You know they [people using
illicit drugs] are doing the whole bag [of heroin mixed with fentanyl] and they donrsquot realize that they canrsquot handle it their
body cant handle itrdquo -- Overdose bystander
Strategies to Address Fentanyl
Overdose Deaths
19
ldquoThe AMA has been a longtime supporter of increasing the availability of Naloxone for patients first responders and bystanders who can help save lives and has provided resources to bolster legislative efforts to increase access to this medication in several statesrdquo
wwwama-assnorgamapubnewsnews20142014-04-
07-naxolene-product-approvalpage
ldquoAPhA supports the pharmacistrsquos
role in selecting appropriate therapy
and dosing and initiating and
providing education about the
proper use of opioid reversal
agents to prevent opioid-related
deaths due to overdoserdquo
wwwpharmacistcompolicycontrolled-substances-and-
other-medications-potential-abuse-and-use-opioid-
reversal-agents-2
Overdose education and naloxone distribution is
a key tool in addressing the overdose crisis
ASAM Board of Directors April 2010
ldquoNaloxone has been proven to be an effective fast-acting inexpensive and non-addictive opioid antagonist with minimal side effects Naloxone can be administered quickly and effectively by trained professional and lay individuals who observe the initial signs of an opioid overdose reactionrdquo
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
Naloxone Basics
21
Patients can go back into overdose if long acting opioids were taken
(fentanyl patch methadone extended release morphine extended release oxycodone)
Patients should avoid taking more opioids after naloxone administration so they do not go back into overdose after naloxone wears off
Patients may want to take more opioids during this time because they may feel withdrawal symptoms
Wears off in 30 - 90 minutes
Store at room temperature to minimize degradation
Shelf-life is 12-24 months
If patient is not responding in this time a second dose may need be administered
Takes effect in 2 - 3 minutes
21
Naloxone Formulations
Intranasal with atomizer attachment Auto-Injector
Intranasal spray Intramuscular injection
Rationale for Overdose Education
and Naloxone Rescue Kits bull Most people who use opioids do not use
alone
bull Known risk factors
Mixing substances loss of opioid
tolerance using alone unknown
source
bull Opportunity window
Opioid overdoses take minutes to hours
and is reversible with naloxone
Fentanyl reduces the window to seconds
to minutes
bull Bystanders are trainable to
recognize and respond to overdoses
bull Fear of public safety 23
Evaluations of Overdose Education and Naloxone Distribution Programs
24
Feasibility
bull Piper et al Subst Use Misuse 2008 43 858-70 bull Doe-Simkins et al Am J Public Health 2009 99 788-791 bull Enteen et al J Urban Health 201087 931-41 bull Bennett et al J Urban Health 2011 88 1020-30 bull Walley et al JSAT 2013 44241-7 (Methadone and detox programs)
Increased knowledge and skills
bull Green et al Addiction 2008 103979-89 bull Tobin et al Int J Drug Policy 2009 20 131-6 bull Wagner et al Int J Drug Policy 2010 21 186-93
No increase in use increase in drug
treatment
bull Seal et al J Urban Health 200582303-11 bull Doe-Simkins et al BMC Public Health 2014 14297 bull Jones et al Addictive Behaviors 201771104-6
Reduction in overdose in communities
bull Maxwell et al J Addict Dis 200625 89-96 bull Evans et al Am J Epidemiol 2012 174 302-8 bull Walley et al BMJ 2013 346 f174 bull Bird et al Addiction 2015 Dec 1 bull Coffin et al Ann Intern Med 2016 1-8
Cost-effective
$438 (best) to $14000 (worst ) per quality-
adjusted life year gained
bull Coffin and Sullivan Ann Intern Med 2013 Jan 1158(1)1-9
25
Objective Determine the impact of
opioid overdose education with
intranasal naloxone distribution
(OEND) programs on fatal and non-
fatal opioid overdose rates in
Massachusetts
Walley et al BMJ 2013 346 f174
INPEDE OD (Intranasal Naloxone and Prevention Educationrsquos Effect on
Overdose Study)
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
26
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
OEND programs 2006-07
27
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
28
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
29
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
Towns without
30
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
Fatal Opioid Overdose Rates by
OEND Implementation
31
Cumulative enrollments per 100k RR ARR 95 CI
Absolute model
No enrollment Ref Ref Ref
Low implementation 1-100 093 073 057-091
High implementation gt 100 082 054 039-076
Adjusted Rate Ratios (ARR) All rate ratios adjusted for the citytown
population rates of age under 18 male race ethnicity (hispanic white black other) below poverty level medically supervised
inpatient withdrawal treatment methadone treatment BSAS-funded buprenorphine treatment prescriptions to doctor shoppers and
year
Walley et al BMJ 2013 346 f174
Naloxone coverage per 100K
0
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
Opioid overdose death rate
27 reduction
32
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Educational Objectives
4
bull At the conclusion of this activity participants should
be able to
Review the epidemiology of opioid overdose
Describe the rationale for and scope of overdose education
and naloxone distribution (OEND) programs
Implement OEND in settings that offer medication for opioid
use disorder
ndash Educate patients about overdose risk reduction
ndash Prescribe naloxone rescue kits
Case 29 yo woman presents to
clinic for buprenorphine treatment
5
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12 step program
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman on
buprenorphine treatment
6
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine toxicology only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
7
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine toxicology only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Hospitalized in intensive care for overdose
Her boyfriend was released from jail and returned to stay with her
He relapsed and overdosed on heroin on the 3rd night ndash likely fentanyl
minus Packed his underwear with ice tried to rescue breathe but did not
respond so she called 911 and they were unable to save him
minus Child protection was notified about the incident and they removed
her son from the home
She stopped buprenorphine started drinking alcohol then relapsed
to heroinfentanyl and overdosed
Case 29 yo woman on
buprenorphine treatment
8
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine toxicology only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Hospitalized in intensive care for overdose
Her boyfriend was released from jail and returned to stay with her
He relapsed and overdosed on heroin on the 3rd night ndash likely fentanyl
minus Packed his underwear with ice tried to rescue breathe but did not
respond so she called 911 and they were unable to save him
minus Child protection was notified about the incident and they removed
her son from the home
She stopped buprenorphine started drinking alcohol then relapsed
to heroinfentanyl and overdosed
How could overdose prevention improve this case
Overdose continues to increase and is the
leading cause of accidental injury death
10
Rates of Drug Overdose Deaths
by State Change from 2010 to 2015
Rudd et al 2016
bull Opioid death rates increased by 156 from 2014 to 2015
bull Increase driven by synthetic opioids (illicitly-manufactured fentanyl and heroin)
bull Increases in these opioid subcategories occurred overall and across all demographics and regions
Alpert A Powell D Pacula RL Supply-Side Drug Policy in the
Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic
Research 2017 Jan 5
Overdose deaths since
2010 are driven by
heroin and fentanyl
not prescription opioids
Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three
Years NYT ndash The UpShot 922017
Fentanyl is Driving Overdose Surge
12
13
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
14
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
15
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
16
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
17
Boston Globe ndash December 27 2015
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
18
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
Public health response to address overdoses related to illicitly made fentanyl
1 Fentanyl should be included on standard toxicology screens
2 Adapt existing harm reduction strategies such as direct observation of anyone using illicit
opioids and ensuring bystanders are equipped with naloxone
3 Enhanced access and linkage to medication for opioid use disorders
ldquoSo now what they [people selling illicit drugs] are doing is theyrsquore cutting the heroin with the fentanyl to make it stronger
And the dope [heroin] is so strong with the fentanyl in it that you get the whole dose of the fentanyl at once rather than
being time-released [like the patch] And thatrsquos why people are dyingmdashplain and simple You know they [people using
illicit drugs] are doing the whole bag [of heroin mixed with fentanyl] and they donrsquot realize that they canrsquot handle it their
body cant handle itrdquo -- Overdose bystander
Strategies to Address Fentanyl
Overdose Deaths
19
ldquoThe AMA has been a longtime supporter of increasing the availability of Naloxone for patients first responders and bystanders who can help save lives and has provided resources to bolster legislative efforts to increase access to this medication in several statesrdquo
wwwama-assnorgamapubnewsnews20142014-04-
07-naxolene-product-approvalpage
ldquoAPhA supports the pharmacistrsquos
role in selecting appropriate therapy
and dosing and initiating and
providing education about the
proper use of opioid reversal
agents to prevent opioid-related
deaths due to overdoserdquo
wwwpharmacistcompolicycontrolled-substances-and-
other-medications-potential-abuse-and-use-opioid-
reversal-agents-2
Overdose education and naloxone distribution is
a key tool in addressing the overdose crisis
ASAM Board of Directors April 2010
ldquoNaloxone has been proven to be an effective fast-acting inexpensive and non-addictive opioid antagonist with minimal side effects Naloxone can be administered quickly and effectively by trained professional and lay individuals who observe the initial signs of an opioid overdose reactionrdquo
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
Naloxone Basics
21
Patients can go back into overdose if long acting opioids were taken
(fentanyl patch methadone extended release morphine extended release oxycodone)
Patients should avoid taking more opioids after naloxone administration so they do not go back into overdose after naloxone wears off
Patients may want to take more opioids during this time because they may feel withdrawal symptoms
Wears off in 30 - 90 minutes
Store at room temperature to minimize degradation
Shelf-life is 12-24 months
If patient is not responding in this time a second dose may need be administered
Takes effect in 2 - 3 minutes
21
Naloxone Formulations
Intranasal with atomizer attachment Auto-Injector
Intranasal spray Intramuscular injection
Rationale for Overdose Education
and Naloxone Rescue Kits bull Most people who use opioids do not use
alone
bull Known risk factors
Mixing substances loss of opioid
tolerance using alone unknown
source
bull Opportunity window
Opioid overdoses take minutes to hours
and is reversible with naloxone
Fentanyl reduces the window to seconds
to minutes
bull Bystanders are trainable to
recognize and respond to overdoses
bull Fear of public safety 23
Evaluations of Overdose Education and Naloxone Distribution Programs
24
Feasibility
bull Piper et al Subst Use Misuse 2008 43 858-70 bull Doe-Simkins et al Am J Public Health 2009 99 788-791 bull Enteen et al J Urban Health 201087 931-41 bull Bennett et al J Urban Health 2011 88 1020-30 bull Walley et al JSAT 2013 44241-7 (Methadone and detox programs)
Increased knowledge and skills
bull Green et al Addiction 2008 103979-89 bull Tobin et al Int J Drug Policy 2009 20 131-6 bull Wagner et al Int J Drug Policy 2010 21 186-93
No increase in use increase in drug
treatment
bull Seal et al J Urban Health 200582303-11 bull Doe-Simkins et al BMC Public Health 2014 14297 bull Jones et al Addictive Behaviors 201771104-6
Reduction in overdose in communities
bull Maxwell et al J Addict Dis 200625 89-96 bull Evans et al Am J Epidemiol 2012 174 302-8 bull Walley et al BMJ 2013 346 f174 bull Bird et al Addiction 2015 Dec 1 bull Coffin et al Ann Intern Med 2016 1-8
Cost-effective
$438 (best) to $14000 (worst ) per quality-
adjusted life year gained
bull Coffin and Sullivan Ann Intern Med 2013 Jan 1158(1)1-9
25
Objective Determine the impact of
opioid overdose education with
intranasal naloxone distribution
(OEND) programs on fatal and non-
fatal opioid overdose rates in
Massachusetts
Walley et al BMJ 2013 346 f174
INPEDE OD (Intranasal Naloxone and Prevention Educationrsquos Effect on
Overdose Study)
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
26
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
OEND programs 2006-07
27
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
28
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
29
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
Towns without
30
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
Fatal Opioid Overdose Rates by
OEND Implementation
31
Cumulative enrollments per 100k RR ARR 95 CI
Absolute model
No enrollment Ref Ref Ref
Low implementation 1-100 093 073 057-091
High implementation gt 100 082 054 039-076
Adjusted Rate Ratios (ARR) All rate ratios adjusted for the citytown
population rates of age under 18 male race ethnicity (hispanic white black other) below poverty level medically supervised
inpatient withdrawal treatment methadone treatment BSAS-funded buprenorphine treatment prescriptions to doctor shoppers and
year
Walley et al BMJ 2013 346 f174
Naloxone coverage per 100K
0
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
Opioid overdose death rate
27 reduction
32
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Case 29 yo woman presents to
clinic for buprenorphine treatment
5
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12 step program
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman on
buprenorphine treatment
6
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine toxicology only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
7
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine toxicology only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Hospitalized in intensive care for overdose
Her boyfriend was released from jail and returned to stay with her
He relapsed and overdosed on heroin on the 3rd night ndash likely fentanyl
minus Packed his underwear with ice tried to rescue breathe but did not
respond so she called 911 and they were unable to save him
minus Child protection was notified about the incident and they removed
her son from the home
She stopped buprenorphine started drinking alcohol then relapsed
to heroinfentanyl and overdosed
Case 29 yo woman on
buprenorphine treatment
8
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine toxicology only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Hospitalized in intensive care for overdose
Her boyfriend was released from jail and returned to stay with her
He relapsed and overdosed on heroin on the 3rd night ndash likely fentanyl
minus Packed his underwear with ice tried to rescue breathe but did not
respond so she called 911 and they were unable to save him
minus Child protection was notified about the incident and they removed
her son from the home
She stopped buprenorphine started drinking alcohol then relapsed
to heroinfentanyl and overdosed
How could overdose prevention improve this case
Overdose continues to increase and is the
leading cause of accidental injury death
10
Rates of Drug Overdose Deaths
by State Change from 2010 to 2015
Rudd et al 2016
bull Opioid death rates increased by 156 from 2014 to 2015
bull Increase driven by synthetic opioids (illicitly-manufactured fentanyl and heroin)
bull Increases in these opioid subcategories occurred overall and across all demographics and regions
Alpert A Powell D Pacula RL Supply-Side Drug Policy in the
Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic
Research 2017 Jan 5
Overdose deaths since
2010 are driven by
heroin and fentanyl
not prescription opioids
Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three
Years NYT ndash The UpShot 922017
Fentanyl is Driving Overdose Surge
12
13
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
14
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
15
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
16
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
17
Boston Globe ndash December 27 2015
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
18
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
Public health response to address overdoses related to illicitly made fentanyl
1 Fentanyl should be included on standard toxicology screens
2 Adapt existing harm reduction strategies such as direct observation of anyone using illicit
opioids and ensuring bystanders are equipped with naloxone
3 Enhanced access and linkage to medication for opioid use disorders
ldquoSo now what they [people selling illicit drugs] are doing is theyrsquore cutting the heroin with the fentanyl to make it stronger
And the dope [heroin] is so strong with the fentanyl in it that you get the whole dose of the fentanyl at once rather than
being time-released [like the patch] And thatrsquos why people are dyingmdashplain and simple You know they [people using
illicit drugs] are doing the whole bag [of heroin mixed with fentanyl] and they donrsquot realize that they canrsquot handle it their
body cant handle itrdquo -- Overdose bystander
Strategies to Address Fentanyl
Overdose Deaths
19
ldquoThe AMA has been a longtime supporter of increasing the availability of Naloxone for patients first responders and bystanders who can help save lives and has provided resources to bolster legislative efforts to increase access to this medication in several statesrdquo
wwwama-assnorgamapubnewsnews20142014-04-
07-naxolene-product-approvalpage
ldquoAPhA supports the pharmacistrsquos
role in selecting appropriate therapy
and dosing and initiating and
providing education about the
proper use of opioid reversal
agents to prevent opioid-related
deaths due to overdoserdquo
wwwpharmacistcompolicycontrolled-substances-and-
other-medications-potential-abuse-and-use-opioid-
reversal-agents-2
Overdose education and naloxone distribution is
a key tool in addressing the overdose crisis
ASAM Board of Directors April 2010
ldquoNaloxone has been proven to be an effective fast-acting inexpensive and non-addictive opioid antagonist with minimal side effects Naloxone can be administered quickly and effectively by trained professional and lay individuals who observe the initial signs of an opioid overdose reactionrdquo
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
Naloxone Basics
21
Patients can go back into overdose if long acting opioids were taken
(fentanyl patch methadone extended release morphine extended release oxycodone)
Patients should avoid taking more opioids after naloxone administration so they do not go back into overdose after naloxone wears off
Patients may want to take more opioids during this time because they may feel withdrawal symptoms
Wears off in 30 - 90 minutes
Store at room temperature to minimize degradation
Shelf-life is 12-24 months
If patient is not responding in this time a second dose may need be administered
Takes effect in 2 - 3 minutes
21
Naloxone Formulations
Intranasal with atomizer attachment Auto-Injector
Intranasal spray Intramuscular injection
Rationale for Overdose Education
and Naloxone Rescue Kits bull Most people who use opioids do not use
alone
bull Known risk factors
Mixing substances loss of opioid
tolerance using alone unknown
source
bull Opportunity window
Opioid overdoses take minutes to hours
and is reversible with naloxone
Fentanyl reduces the window to seconds
to minutes
bull Bystanders are trainable to
recognize and respond to overdoses
bull Fear of public safety 23
Evaluations of Overdose Education and Naloxone Distribution Programs
24
Feasibility
bull Piper et al Subst Use Misuse 2008 43 858-70 bull Doe-Simkins et al Am J Public Health 2009 99 788-791 bull Enteen et al J Urban Health 201087 931-41 bull Bennett et al J Urban Health 2011 88 1020-30 bull Walley et al JSAT 2013 44241-7 (Methadone and detox programs)
Increased knowledge and skills
bull Green et al Addiction 2008 103979-89 bull Tobin et al Int J Drug Policy 2009 20 131-6 bull Wagner et al Int J Drug Policy 2010 21 186-93
No increase in use increase in drug
treatment
bull Seal et al J Urban Health 200582303-11 bull Doe-Simkins et al BMC Public Health 2014 14297 bull Jones et al Addictive Behaviors 201771104-6
Reduction in overdose in communities
bull Maxwell et al J Addict Dis 200625 89-96 bull Evans et al Am J Epidemiol 2012 174 302-8 bull Walley et al BMJ 2013 346 f174 bull Bird et al Addiction 2015 Dec 1 bull Coffin et al Ann Intern Med 2016 1-8
Cost-effective
$438 (best) to $14000 (worst ) per quality-
adjusted life year gained
bull Coffin and Sullivan Ann Intern Med 2013 Jan 1158(1)1-9
25
Objective Determine the impact of
opioid overdose education with
intranasal naloxone distribution
(OEND) programs on fatal and non-
fatal opioid overdose rates in
Massachusetts
Walley et al BMJ 2013 346 f174
INPEDE OD (Intranasal Naloxone and Prevention Educationrsquos Effect on
Overdose Study)
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
26
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
OEND programs 2006-07
27
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
28
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
29
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
Towns without
30
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
Fatal Opioid Overdose Rates by
OEND Implementation
31
Cumulative enrollments per 100k RR ARR 95 CI
Absolute model
No enrollment Ref Ref Ref
Low implementation 1-100 093 073 057-091
High implementation gt 100 082 054 039-076
Adjusted Rate Ratios (ARR) All rate ratios adjusted for the citytown
population rates of age under 18 male race ethnicity (hispanic white black other) below poverty level medically supervised
inpatient withdrawal treatment methadone treatment BSAS-funded buprenorphine treatment prescriptions to doctor shoppers and
year
Walley et al BMJ 2013 346 f174
Naloxone coverage per 100K
0
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
Opioid overdose death rate
27 reduction
32
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Case 29 yo woman on
buprenorphine treatment
6
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine toxicology only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
7
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine toxicology only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Hospitalized in intensive care for overdose
Her boyfriend was released from jail and returned to stay with her
He relapsed and overdosed on heroin on the 3rd night ndash likely fentanyl
minus Packed his underwear with ice tried to rescue breathe but did not
respond so she called 911 and they were unable to save him
minus Child protection was notified about the incident and they removed
her son from the home
She stopped buprenorphine started drinking alcohol then relapsed
to heroinfentanyl and overdosed
Case 29 yo woman on
buprenorphine treatment
8
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine toxicology only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Hospitalized in intensive care for overdose
Her boyfriend was released from jail and returned to stay with her
He relapsed and overdosed on heroin on the 3rd night ndash likely fentanyl
minus Packed his underwear with ice tried to rescue breathe but did not
respond so she called 911 and they were unable to save him
minus Child protection was notified about the incident and they removed
her son from the home
She stopped buprenorphine started drinking alcohol then relapsed
to heroinfentanyl and overdosed
How could overdose prevention improve this case
Overdose continues to increase and is the
leading cause of accidental injury death
10
Rates of Drug Overdose Deaths
by State Change from 2010 to 2015
Rudd et al 2016
bull Opioid death rates increased by 156 from 2014 to 2015
bull Increase driven by synthetic opioids (illicitly-manufactured fentanyl and heroin)
bull Increases in these opioid subcategories occurred overall and across all demographics and regions
Alpert A Powell D Pacula RL Supply-Side Drug Policy in the
Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic
Research 2017 Jan 5
Overdose deaths since
2010 are driven by
heroin and fentanyl
not prescription opioids
Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three
Years NYT ndash The UpShot 922017
Fentanyl is Driving Overdose Surge
12
13
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
14
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
15
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
16
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
17
Boston Globe ndash December 27 2015
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
18
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
Public health response to address overdoses related to illicitly made fentanyl
1 Fentanyl should be included on standard toxicology screens
2 Adapt existing harm reduction strategies such as direct observation of anyone using illicit
opioids and ensuring bystanders are equipped with naloxone
3 Enhanced access and linkage to medication for opioid use disorders
ldquoSo now what they [people selling illicit drugs] are doing is theyrsquore cutting the heroin with the fentanyl to make it stronger
And the dope [heroin] is so strong with the fentanyl in it that you get the whole dose of the fentanyl at once rather than
being time-released [like the patch] And thatrsquos why people are dyingmdashplain and simple You know they [people using
illicit drugs] are doing the whole bag [of heroin mixed with fentanyl] and they donrsquot realize that they canrsquot handle it their
body cant handle itrdquo -- Overdose bystander
Strategies to Address Fentanyl
Overdose Deaths
19
ldquoThe AMA has been a longtime supporter of increasing the availability of Naloxone for patients first responders and bystanders who can help save lives and has provided resources to bolster legislative efforts to increase access to this medication in several statesrdquo
wwwama-assnorgamapubnewsnews20142014-04-
07-naxolene-product-approvalpage
ldquoAPhA supports the pharmacistrsquos
role in selecting appropriate therapy
and dosing and initiating and
providing education about the
proper use of opioid reversal
agents to prevent opioid-related
deaths due to overdoserdquo
wwwpharmacistcompolicycontrolled-substances-and-
other-medications-potential-abuse-and-use-opioid-
reversal-agents-2
Overdose education and naloxone distribution is
a key tool in addressing the overdose crisis
ASAM Board of Directors April 2010
ldquoNaloxone has been proven to be an effective fast-acting inexpensive and non-addictive opioid antagonist with minimal side effects Naloxone can be administered quickly and effectively by trained professional and lay individuals who observe the initial signs of an opioid overdose reactionrdquo
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
Naloxone Basics
21
Patients can go back into overdose if long acting opioids were taken
(fentanyl patch methadone extended release morphine extended release oxycodone)
Patients should avoid taking more opioids after naloxone administration so they do not go back into overdose after naloxone wears off
Patients may want to take more opioids during this time because they may feel withdrawal symptoms
Wears off in 30 - 90 minutes
Store at room temperature to minimize degradation
Shelf-life is 12-24 months
If patient is not responding in this time a second dose may need be administered
Takes effect in 2 - 3 minutes
21
Naloxone Formulations
Intranasal with atomizer attachment Auto-Injector
Intranasal spray Intramuscular injection
Rationale for Overdose Education
and Naloxone Rescue Kits bull Most people who use opioids do not use
alone
bull Known risk factors
Mixing substances loss of opioid
tolerance using alone unknown
source
bull Opportunity window
Opioid overdoses take minutes to hours
and is reversible with naloxone
Fentanyl reduces the window to seconds
to minutes
bull Bystanders are trainable to
recognize and respond to overdoses
bull Fear of public safety 23
Evaluations of Overdose Education and Naloxone Distribution Programs
24
Feasibility
bull Piper et al Subst Use Misuse 2008 43 858-70 bull Doe-Simkins et al Am J Public Health 2009 99 788-791 bull Enteen et al J Urban Health 201087 931-41 bull Bennett et al J Urban Health 2011 88 1020-30 bull Walley et al JSAT 2013 44241-7 (Methadone and detox programs)
Increased knowledge and skills
bull Green et al Addiction 2008 103979-89 bull Tobin et al Int J Drug Policy 2009 20 131-6 bull Wagner et al Int J Drug Policy 2010 21 186-93
No increase in use increase in drug
treatment
bull Seal et al J Urban Health 200582303-11 bull Doe-Simkins et al BMC Public Health 2014 14297 bull Jones et al Addictive Behaviors 201771104-6
Reduction in overdose in communities
bull Maxwell et al J Addict Dis 200625 89-96 bull Evans et al Am J Epidemiol 2012 174 302-8 bull Walley et al BMJ 2013 346 f174 bull Bird et al Addiction 2015 Dec 1 bull Coffin et al Ann Intern Med 2016 1-8
Cost-effective
$438 (best) to $14000 (worst ) per quality-
adjusted life year gained
bull Coffin and Sullivan Ann Intern Med 2013 Jan 1158(1)1-9
25
Objective Determine the impact of
opioid overdose education with
intranasal naloxone distribution
(OEND) programs on fatal and non-
fatal opioid overdose rates in
Massachusetts
Walley et al BMJ 2013 346 f174
INPEDE OD (Intranasal Naloxone and Prevention Educationrsquos Effect on
Overdose Study)
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
26
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
OEND programs 2006-07
27
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
28
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
29
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
Towns without
30
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
Fatal Opioid Overdose Rates by
OEND Implementation
31
Cumulative enrollments per 100k RR ARR 95 CI
Absolute model
No enrollment Ref Ref Ref
Low implementation 1-100 093 073 057-091
High implementation gt 100 082 054 039-076
Adjusted Rate Ratios (ARR) All rate ratios adjusted for the citytown
population rates of age under 18 male race ethnicity (hispanic white black other) below poverty level medically supervised
inpatient withdrawal treatment methadone treatment BSAS-funded buprenorphine treatment prescriptions to doctor shoppers and
year
Walley et al BMJ 2013 346 f174
Naloxone coverage per 100K
0
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
Opioid overdose death rate
27 reduction
32
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Case 29 yo woman on
buprenorphine treatment
7
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine toxicology only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Hospitalized in intensive care for overdose
Her boyfriend was released from jail and returned to stay with her
He relapsed and overdosed on heroin on the 3rd night ndash likely fentanyl
minus Packed his underwear with ice tried to rescue breathe but did not
respond so she called 911 and they were unable to save him
minus Child protection was notified about the incident and they removed
her son from the home
She stopped buprenorphine started drinking alcohol then relapsed
to heroinfentanyl and overdosed
Case 29 yo woman on
buprenorphine treatment
8
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine toxicology only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Hospitalized in intensive care for overdose
Her boyfriend was released from jail and returned to stay with her
He relapsed and overdosed on heroin on the 3rd night ndash likely fentanyl
minus Packed his underwear with ice tried to rescue breathe but did not
respond so she called 911 and they were unable to save him
minus Child protection was notified about the incident and they removed
her son from the home
She stopped buprenorphine started drinking alcohol then relapsed
to heroinfentanyl and overdosed
How could overdose prevention improve this case
Overdose continues to increase and is the
leading cause of accidental injury death
10
Rates of Drug Overdose Deaths
by State Change from 2010 to 2015
Rudd et al 2016
bull Opioid death rates increased by 156 from 2014 to 2015
bull Increase driven by synthetic opioids (illicitly-manufactured fentanyl and heroin)
bull Increases in these opioid subcategories occurred overall and across all demographics and regions
Alpert A Powell D Pacula RL Supply-Side Drug Policy in the
Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic
Research 2017 Jan 5
Overdose deaths since
2010 are driven by
heroin and fentanyl
not prescription opioids
Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three
Years NYT ndash The UpShot 922017
Fentanyl is Driving Overdose Surge
12
13
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
14
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
15
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
16
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
17
Boston Globe ndash December 27 2015
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
18
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
Public health response to address overdoses related to illicitly made fentanyl
1 Fentanyl should be included on standard toxicology screens
2 Adapt existing harm reduction strategies such as direct observation of anyone using illicit
opioids and ensuring bystanders are equipped with naloxone
3 Enhanced access and linkage to medication for opioid use disorders
ldquoSo now what they [people selling illicit drugs] are doing is theyrsquore cutting the heroin with the fentanyl to make it stronger
And the dope [heroin] is so strong with the fentanyl in it that you get the whole dose of the fentanyl at once rather than
being time-released [like the patch] And thatrsquos why people are dyingmdashplain and simple You know they [people using
illicit drugs] are doing the whole bag [of heroin mixed with fentanyl] and they donrsquot realize that they canrsquot handle it their
body cant handle itrdquo -- Overdose bystander
Strategies to Address Fentanyl
Overdose Deaths
19
ldquoThe AMA has been a longtime supporter of increasing the availability of Naloxone for patients first responders and bystanders who can help save lives and has provided resources to bolster legislative efforts to increase access to this medication in several statesrdquo
wwwama-assnorgamapubnewsnews20142014-04-
07-naxolene-product-approvalpage
ldquoAPhA supports the pharmacistrsquos
role in selecting appropriate therapy
and dosing and initiating and
providing education about the
proper use of opioid reversal
agents to prevent opioid-related
deaths due to overdoserdquo
wwwpharmacistcompolicycontrolled-substances-and-
other-medications-potential-abuse-and-use-opioid-
reversal-agents-2
Overdose education and naloxone distribution is
a key tool in addressing the overdose crisis
ASAM Board of Directors April 2010
ldquoNaloxone has been proven to be an effective fast-acting inexpensive and non-addictive opioid antagonist with minimal side effects Naloxone can be administered quickly and effectively by trained professional and lay individuals who observe the initial signs of an opioid overdose reactionrdquo
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
Naloxone Basics
21
Patients can go back into overdose if long acting opioids were taken
(fentanyl patch methadone extended release morphine extended release oxycodone)
Patients should avoid taking more opioids after naloxone administration so they do not go back into overdose after naloxone wears off
Patients may want to take more opioids during this time because they may feel withdrawal symptoms
Wears off in 30 - 90 minutes
Store at room temperature to minimize degradation
Shelf-life is 12-24 months
If patient is not responding in this time a second dose may need be administered
Takes effect in 2 - 3 minutes
21
Naloxone Formulations
Intranasal with atomizer attachment Auto-Injector
Intranasal spray Intramuscular injection
Rationale for Overdose Education
and Naloxone Rescue Kits bull Most people who use opioids do not use
alone
bull Known risk factors
Mixing substances loss of opioid
tolerance using alone unknown
source
bull Opportunity window
Opioid overdoses take minutes to hours
and is reversible with naloxone
Fentanyl reduces the window to seconds
to minutes
bull Bystanders are trainable to
recognize and respond to overdoses
bull Fear of public safety 23
Evaluations of Overdose Education and Naloxone Distribution Programs
24
Feasibility
bull Piper et al Subst Use Misuse 2008 43 858-70 bull Doe-Simkins et al Am J Public Health 2009 99 788-791 bull Enteen et al J Urban Health 201087 931-41 bull Bennett et al J Urban Health 2011 88 1020-30 bull Walley et al JSAT 2013 44241-7 (Methadone and detox programs)
Increased knowledge and skills
bull Green et al Addiction 2008 103979-89 bull Tobin et al Int J Drug Policy 2009 20 131-6 bull Wagner et al Int J Drug Policy 2010 21 186-93
No increase in use increase in drug
treatment
bull Seal et al J Urban Health 200582303-11 bull Doe-Simkins et al BMC Public Health 2014 14297 bull Jones et al Addictive Behaviors 201771104-6
Reduction in overdose in communities
bull Maxwell et al J Addict Dis 200625 89-96 bull Evans et al Am J Epidemiol 2012 174 302-8 bull Walley et al BMJ 2013 346 f174 bull Bird et al Addiction 2015 Dec 1 bull Coffin et al Ann Intern Med 2016 1-8
Cost-effective
$438 (best) to $14000 (worst ) per quality-
adjusted life year gained
bull Coffin and Sullivan Ann Intern Med 2013 Jan 1158(1)1-9
25
Objective Determine the impact of
opioid overdose education with
intranasal naloxone distribution
(OEND) programs on fatal and non-
fatal opioid overdose rates in
Massachusetts
Walley et al BMJ 2013 346 f174
INPEDE OD (Intranasal Naloxone and Prevention Educationrsquos Effect on
Overdose Study)
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
26
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
OEND programs 2006-07
27
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
28
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
29
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
Towns without
30
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
Fatal Opioid Overdose Rates by
OEND Implementation
31
Cumulative enrollments per 100k RR ARR 95 CI
Absolute model
No enrollment Ref Ref Ref
Low implementation 1-100 093 073 057-091
High implementation gt 100 082 054 039-076
Adjusted Rate Ratios (ARR) All rate ratios adjusted for the citytown
population rates of age under 18 male race ethnicity (hispanic white black other) below poverty level medically supervised
inpatient withdrawal treatment methadone treatment BSAS-funded buprenorphine treatment prescriptions to doctor shoppers and
year
Walley et al BMJ 2013 346 f174
Naloxone coverage per 100K
0
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
Opioid overdose death rate
27 reduction
32
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Case 29 yo woman on
buprenorphine treatment
8
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine toxicology only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Hospitalized in intensive care for overdose
Her boyfriend was released from jail and returned to stay with her
He relapsed and overdosed on heroin on the 3rd night ndash likely fentanyl
minus Packed his underwear with ice tried to rescue breathe but did not
respond so she called 911 and they were unable to save him
minus Child protection was notified about the incident and they removed
her son from the home
She stopped buprenorphine started drinking alcohol then relapsed
to heroinfentanyl and overdosed
How could overdose prevention improve this case
Overdose continues to increase and is the
leading cause of accidental injury death
10
Rates of Drug Overdose Deaths
by State Change from 2010 to 2015
Rudd et al 2016
bull Opioid death rates increased by 156 from 2014 to 2015
bull Increase driven by synthetic opioids (illicitly-manufactured fentanyl and heroin)
bull Increases in these opioid subcategories occurred overall and across all demographics and regions
Alpert A Powell D Pacula RL Supply-Side Drug Policy in the
Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic
Research 2017 Jan 5
Overdose deaths since
2010 are driven by
heroin and fentanyl
not prescription opioids
Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three
Years NYT ndash The UpShot 922017
Fentanyl is Driving Overdose Surge
12
13
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
14
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
15
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
16
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
17
Boston Globe ndash December 27 2015
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
18
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
Public health response to address overdoses related to illicitly made fentanyl
1 Fentanyl should be included on standard toxicology screens
2 Adapt existing harm reduction strategies such as direct observation of anyone using illicit
opioids and ensuring bystanders are equipped with naloxone
3 Enhanced access and linkage to medication for opioid use disorders
ldquoSo now what they [people selling illicit drugs] are doing is theyrsquore cutting the heroin with the fentanyl to make it stronger
And the dope [heroin] is so strong with the fentanyl in it that you get the whole dose of the fentanyl at once rather than
being time-released [like the patch] And thatrsquos why people are dyingmdashplain and simple You know they [people using
illicit drugs] are doing the whole bag [of heroin mixed with fentanyl] and they donrsquot realize that they canrsquot handle it their
body cant handle itrdquo -- Overdose bystander
Strategies to Address Fentanyl
Overdose Deaths
19
ldquoThe AMA has been a longtime supporter of increasing the availability of Naloxone for patients first responders and bystanders who can help save lives and has provided resources to bolster legislative efforts to increase access to this medication in several statesrdquo
wwwama-assnorgamapubnewsnews20142014-04-
07-naxolene-product-approvalpage
ldquoAPhA supports the pharmacistrsquos
role in selecting appropriate therapy
and dosing and initiating and
providing education about the
proper use of opioid reversal
agents to prevent opioid-related
deaths due to overdoserdquo
wwwpharmacistcompolicycontrolled-substances-and-
other-medications-potential-abuse-and-use-opioid-
reversal-agents-2
Overdose education and naloxone distribution is
a key tool in addressing the overdose crisis
ASAM Board of Directors April 2010
ldquoNaloxone has been proven to be an effective fast-acting inexpensive and non-addictive opioid antagonist with minimal side effects Naloxone can be administered quickly and effectively by trained professional and lay individuals who observe the initial signs of an opioid overdose reactionrdquo
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
Naloxone Basics
21
Patients can go back into overdose if long acting opioids were taken
(fentanyl patch methadone extended release morphine extended release oxycodone)
Patients should avoid taking more opioids after naloxone administration so they do not go back into overdose after naloxone wears off
Patients may want to take more opioids during this time because they may feel withdrawal symptoms
Wears off in 30 - 90 minutes
Store at room temperature to minimize degradation
Shelf-life is 12-24 months
If patient is not responding in this time a second dose may need be administered
Takes effect in 2 - 3 minutes
21
Naloxone Formulations
Intranasal with atomizer attachment Auto-Injector
Intranasal spray Intramuscular injection
Rationale for Overdose Education
and Naloxone Rescue Kits bull Most people who use opioids do not use
alone
bull Known risk factors
Mixing substances loss of opioid
tolerance using alone unknown
source
bull Opportunity window
Opioid overdoses take minutes to hours
and is reversible with naloxone
Fentanyl reduces the window to seconds
to minutes
bull Bystanders are trainable to
recognize and respond to overdoses
bull Fear of public safety 23
Evaluations of Overdose Education and Naloxone Distribution Programs
24
Feasibility
bull Piper et al Subst Use Misuse 2008 43 858-70 bull Doe-Simkins et al Am J Public Health 2009 99 788-791 bull Enteen et al J Urban Health 201087 931-41 bull Bennett et al J Urban Health 2011 88 1020-30 bull Walley et al JSAT 2013 44241-7 (Methadone and detox programs)
Increased knowledge and skills
bull Green et al Addiction 2008 103979-89 bull Tobin et al Int J Drug Policy 2009 20 131-6 bull Wagner et al Int J Drug Policy 2010 21 186-93
No increase in use increase in drug
treatment
bull Seal et al J Urban Health 200582303-11 bull Doe-Simkins et al BMC Public Health 2014 14297 bull Jones et al Addictive Behaviors 201771104-6
Reduction in overdose in communities
bull Maxwell et al J Addict Dis 200625 89-96 bull Evans et al Am J Epidemiol 2012 174 302-8 bull Walley et al BMJ 2013 346 f174 bull Bird et al Addiction 2015 Dec 1 bull Coffin et al Ann Intern Med 2016 1-8
Cost-effective
$438 (best) to $14000 (worst ) per quality-
adjusted life year gained
bull Coffin and Sullivan Ann Intern Med 2013 Jan 1158(1)1-9
25
Objective Determine the impact of
opioid overdose education with
intranasal naloxone distribution
(OEND) programs on fatal and non-
fatal opioid overdose rates in
Massachusetts
Walley et al BMJ 2013 346 f174
INPEDE OD (Intranasal Naloxone and Prevention Educationrsquos Effect on
Overdose Study)
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
26
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
OEND programs 2006-07
27
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
28
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
29
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
Towns without
30
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
Fatal Opioid Overdose Rates by
OEND Implementation
31
Cumulative enrollments per 100k RR ARR 95 CI
Absolute model
No enrollment Ref Ref Ref
Low implementation 1-100 093 073 057-091
High implementation gt 100 082 054 039-076
Adjusted Rate Ratios (ARR) All rate ratios adjusted for the citytown
population rates of age under 18 male race ethnicity (hispanic white black other) below poverty level medically supervised
inpatient withdrawal treatment methadone treatment BSAS-funded buprenorphine treatment prescriptions to doctor shoppers and
year
Walley et al BMJ 2013 346 f174
Naloxone coverage per 100K
0
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
Opioid overdose death rate
27 reduction
32
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Overdose continues to increase and is the
leading cause of accidental injury death
10
Rates of Drug Overdose Deaths
by State Change from 2010 to 2015
Rudd et al 2016
bull Opioid death rates increased by 156 from 2014 to 2015
bull Increase driven by synthetic opioids (illicitly-manufactured fentanyl and heroin)
bull Increases in these opioid subcategories occurred overall and across all demographics and regions
Alpert A Powell D Pacula RL Supply-Side Drug Policy in the
Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic
Research 2017 Jan 5
Overdose deaths since
2010 are driven by
heroin and fentanyl
not prescription opioids
Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three
Years NYT ndash The UpShot 922017
Fentanyl is Driving Overdose Surge
12
13
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
14
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
15
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
16
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
17
Boston Globe ndash December 27 2015
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
18
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
Public health response to address overdoses related to illicitly made fentanyl
1 Fentanyl should be included on standard toxicology screens
2 Adapt existing harm reduction strategies such as direct observation of anyone using illicit
opioids and ensuring bystanders are equipped with naloxone
3 Enhanced access and linkage to medication for opioid use disorders
ldquoSo now what they [people selling illicit drugs] are doing is theyrsquore cutting the heroin with the fentanyl to make it stronger
And the dope [heroin] is so strong with the fentanyl in it that you get the whole dose of the fentanyl at once rather than
being time-released [like the patch] And thatrsquos why people are dyingmdashplain and simple You know they [people using
illicit drugs] are doing the whole bag [of heroin mixed with fentanyl] and they donrsquot realize that they canrsquot handle it their
body cant handle itrdquo -- Overdose bystander
Strategies to Address Fentanyl
Overdose Deaths
19
ldquoThe AMA has been a longtime supporter of increasing the availability of Naloxone for patients first responders and bystanders who can help save lives and has provided resources to bolster legislative efforts to increase access to this medication in several statesrdquo
wwwama-assnorgamapubnewsnews20142014-04-
07-naxolene-product-approvalpage
ldquoAPhA supports the pharmacistrsquos
role in selecting appropriate therapy
and dosing and initiating and
providing education about the
proper use of opioid reversal
agents to prevent opioid-related
deaths due to overdoserdquo
wwwpharmacistcompolicycontrolled-substances-and-
other-medications-potential-abuse-and-use-opioid-
reversal-agents-2
Overdose education and naloxone distribution is
a key tool in addressing the overdose crisis
ASAM Board of Directors April 2010
ldquoNaloxone has been proven to be an effective fast-acting inexpensive and non-addictive opioid antagonist with minimal side effects Naloxone can be administered quickly and effectively by trained professional and lay individuals who observe the initial signs of an opioid overdose reactionrdquo
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
Naloxone Basics
21
Patients can go back into overdose if long acting opioids were taken
(fentanyl patch methadone extended release morphine extended release oxycodone)
Patients should avoid taking more opioids after naloxone administration so they do not go back into overdose after naloxone wears off
Patients may want to take more opioids during this time because they may feel withdrawal symptoms
Wears off in 30 - 90 minutes
Store at room temperature to minimize degradation
Shelf-life is 12-24 months
If patient is not responding in this time a second dose may need be administered
Takes effect in 2 - 3 minutes
21
Naloxone Formulations
Intranasal with atomizer attachment Auto-Injector
Intranasal spray Intramuscular injection
Rationale for Overdose Education
and Naloxone Rescue Kits bull Most people who use opioids do not use
alone
bull Known risk factors
Mixing substances loss of opioid
tolerance using alone unknown
source
bull Opportunity window
Opioid overdoses take minutes to hours
and is reversible with naloxone
Fentanyl reduces the window to seconds
to minutes
bull Bystanders are trainable to
recognize and respond to overdoses
bull Fear of public safety 23
Evaluations of Overdose Education and Naloxone Distribution Programs
24
Feasibility
bull Piper et al Subst Use Misuse 2008 43 858-70 bull Doe-Simkins et al Am J Public Health 2009 99 788-791 bull Enteen et al J Urban Health 201087 931-41 bull Bennett et al J Urban Health 2011 88 1020-30 bull Walley et al JSAT 2013 44241-7 (Methadone and detox programs)
Increased knowledge and skills
bull Green et al Addiction 2008 103979-89 bull Tobin et al Int J Drug Policy 2009 20 131-6 bull Wagner et al Int J Drug Policy 2010 21 186-93
No increase in use increase in drug
treatment
bull Seal et al J Urban Health 200582303-11 bull Doe-Simkins et al BMC Public Health 2014 14297 bull Jones et al Addictive Behaviors 201771104-6
Reduction in overdose in communities
bull Maxwell et al J Addict Dis 200625 89-96 bull Evans et al Am J Epidemiol 2012 174 302-8 bull Walley et al BMJ 2013 346 f174 bull Bird et al Addiction 2015 Dec 1 bull Coffin et al Ann Intern Med 2016 1-8
Cost-effective
$438 (best) to $14000 (worst ) per quality-
adjusted life year gained
bull Coffin and Sullivan Ann Intern Med 2013 Jan 1158(1)1-9
25
Objective Determine the impact of
opioid overdose education with
intranasal naloxone distribution
(OEND) programs on fatal and non-
fatal opioid overdose rates in
Massachusetts
Walley et al BMJ 2013 346 f174
INPEDE OD (Intranasal Naloxone and Prevention Educationrsquos Effect on
Overdose Study)
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
26
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
OEND programs 2006-07
27
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
28
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
29
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
Towns without
30
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
Fatal Opioid Overdose Rates by
OEND Implementation
31
Cumulative enrollments per 100k RR ARR 95 CI
Absolute model
No enrollment Ref Ref Ref
Low implementation 1-100 093 073 057-091
High implementation gt 100 082 054 039-076
Adjusted Rate Ratios (ARR) All rate ratios adjusted for the citytown
population rates of age under 18 male race ethnicity (hispanic white black other) below poverty level medically supervised
inpatient withdrawal treatment methadone treatment BSAS-funded buprenorphine treatment prescriptions to doctor shoppers and
year
Walley et al BMJ 2013 346 f174
Naloxone coverage per 100K
0
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
Opioid overdose death rate
27 reduction
32
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
10
Rates of Drug Overdose Deaths
by State Change from 2010 to 2015
Rudd et al 2016
bull Opioid death rates increased by 156 from 2014 to 2015
bull Increase driven by synthetic opioids (illicitly-manufactured fentanyl and heroin)
bull Increases in these opioid subcategories occurred overall and across all demographics and regions
Alpert A Powell D Pacula RL Supply-Side Drug Policy in the
Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic
Research 2017 Jan 5
Overdose deaths since
2010 are driven by
heroin and fentanyl
not prescription opioids
Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three
Years NYT ndash The UpShot 922017
Fentanyl is Driving Overdose Surge
12
13
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
14
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
15
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
16
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
17
Boston Globe ndash December 27 2015
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
18
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
Public health response to address overdoses related to illicitly made fentanyl
1 Fentanyl should be included on standard toxicology screens
2 Adapt existing harm reduction strategies such as direct observation of anyone using illicit
opioids and ensuring bystanders are equipped with naloxone
3 Enhanced access and linkage to medication for opioid use disorders
ldquoSo now what they [people selling illicit drugs] are doing is theyrsquore cutting the heroin with the fentanyl to make it stronger
And the dope [heroin] is so strong with the fentanyl in it that you get the whole dose of the fentanyl at once rather than
being time-released [like the patch] And thatrsquos why people are dyingmdashplain and simple You know they [people using
illicit drugs] are doing the whole bag [of heroin mixed with fentanyl] and they donrsquot realize that they canrsquot handle it their
body cant handle itrdquo -- Overdose bystander
Strategies to Address Fentanyl
Overdose Deaths
19
ldquoThe AMA has been a longtime supporter of increasing the availability of Naloxone for patients first responders and bystanders who can help save lives and has provided resources to bolster legislative efforts to increase access to this medication in several statesrdquo
wwwama-assnorgamapubnewsnews20142014-04-
07-naxolene-product-approvalpage
ldquoAPhA supports the pharmacistrsquos
role in selecting appropriate therapy
and dosing and initiating and
providing education about the
proper use of opioid reversal
agents to prevent opioid-related
deaths due to overdoserdquo
wwwpharmacistcompolicycontrolled-substances-and-
other-medications-potential-abuse-and-use-opioid-
reversal-agents-2
Overdose education and naloxone distribution is
a key tool in addressing the overdose crisis
ASAM Board of Directors April 2010
ldquoNaloxone has been proven to be an effective fast-acting inexpensive and non-addictive opioid antagonist with minimal side effects Naloxone can be administered quickly and effectively by trained professional and lay individuals who observe the initial signs of an opioid overdose reactionrdquo
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
Naloxone Basics
21
Patients can go back into overdose if long acting opioids were taken
(fentanyl patch methadone extended release morphine extended release oxycodone)
Patients should avoid taking more opioids after naloxone administration so they do not go back into overdose after naloxone wears off
Patients may want to take more opioids during this time because they may feel withdrawal symptoms
Wears off in 30 - 90 minutes
Store at room temperature to minimize degradation
Shelf-life is 12-24 months
If patient is not responding in this time a second dose may need be administered
Takes effect in 2 - 3 minutes
21
Naloxone Formulations
Intranasal with atomizer attachment Auto-Injector
Intranasal spray Intramuscular injection
Rationale for Overdose Education
and Naloxone Rescue Kits bull Most people who use opioids do not use
alone
bull Known risk factors
Mixing substances loss of opioid
tolerance using alone unknown
source
bull Opportunity window
Opioid overdoses take minutes to hours
and is reversible with naloxone
Fentanyl reduces the window to seconds
to minutes
bull Bystanders are trainable to
recognize and respond to overdoses
bull Fear of public safety 23
Evaluations of Overdose Education and Naloxone Distribution Programs
24
Feasibility
bull Piper et al Subst Use Misuse 2008 43 858-70 bull Doe-Simkins et al Am J Public Health 2009 99 788-791 bull Enteen et al J Urban Health 201087 931-41 bull Bennett et al J Urban Health 2011 88 1020-30 bull Walley et al JSAT 2013 44241-7 (Methadone and detox programs)
Increased knowledge and skills
bull Green et al Addiction 2008 103979-89 bull Tobin et al Int J Drug Policy 2009 20 131-6 bull Wagner et al Int J Drug Policy 2010 21 186-93
No increase in use increase in drug
treatment
bull Seal et al J Urban Health 200582303-11 bull Doe-Simkins et al BMC Public Health 2014 14297 bull Jones et al Addictive Behaviors 201771104-6
Reduction in overdose in communities
bull Maxwell et al J Addict Dis 200625 89-96 bull Evans et al Am J Epidemiol 2012 174 302-8 bull Walley et al BMJ 2013 346 f174 bull Bird et al Addiction 2015 Dec 1 bull Coffin et al Ann Intern Med 2016 1-8
Cost-effective
$438 (best) to $14000 (worst ) per quality-
adjusted life year gained
bull Coffin and Sullivan Ann Intern Med 2013 Jan 1158(1)1-9
25
Objective Determine the impact of
opioid overdose education with
intranasal naloxone distribution
(OEND) programs on fatal and non-
fatal opioid overdose rates in
Massachusetts
Walley et al BMJ 2013 346 f174
INPEDE OD (Intranasal Naloxone and Prevention Educationrsquos Effect on
Overdose Study)
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
26
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
OEND programs 2006-07
27
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
28
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
29
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
Towns without
30
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
Fatal Opioid Overdose Rates by
OEND Implementation
31
Cumulative enrollments per 100k RR ARR 95 CI
Absolute model
No enrollment Ref Ref Ref
Low implementation 1-100 093 073 057-091
High implementation gt 100 082 054 039-076
Adjusted Rate Ratios (ARR) All rate ratios adjusted for the citytown
population rates of age under 18 male race ethnicity (hispanic white black other) below poverty level medically supervised
inpatient withdrawal treatment methadone treatment BSAS-funded buprenorphine treatment prescriptions to doctor shoppers and
year
Walley et al BMJ 2013 346 f174
Naloxone coverage per 100K
0
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
Opioid overdose death rate
27 reduction
32
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Alpert A Powell D Pacula RL Supply-Side Drug Policy in the
Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic
Research 2017 Jan 5
Overdose deaths since
2010 are driven by
heroin and fentanyl
not prescription opioids
Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three
Years NYT ndash The UpShot 922017
Fentanyl is Driving Overdose Surge
12
13
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
14
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
15
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
16
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
17
Boston Globe ndash December 27 2015
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
18
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
Public health response to address overdoses related to illicitly made fentanyl
1 Fentanyl should be included on standard toxicology screens
2 Adapt existing harm reduction strategies such as direct observation of anyone using illicit
opioids and ensuring bystanders are equipped with naloxone
3 Enhanced access and linkage to medication for opioid use disorders
ldquoSo now what they [people selling illicit drugs] are doing is theyrsquore cutting the heroin with the fentanyl to make it stronger
And the dope [heroin] is so strong with the fentanyl in it that you get the whole dose of the fentanyl at once rather than
being time-released [like the patch] And thatrsquos why people are dyingmdashplain and simple You know they [people using
illicit drugs] are doing the whole bag [of heroin mixed with fentanyl] and they donrsquot realize that they canrsquot handle it their
body cant handle itrdquo -- Overdose bystander
Strategies to Address Fentanyl
Overdose Deaths
19
ldquoThe AMA has been a longtime supporter of increasing the availability of Naloxone for patients first responders and bystanders who can help save lives and has provided resources to bolster legislative efforts to increase access to this medication in several statesrdquo
wwwama-assnorgamapubnewsnews20142014-04-
07-naxolene-product-approvalpage
ldquoAPhA supports the pharmacistrsquos
role in selecting appropriate therapy
and dosing and initiating and
providing education about the
proper use of opioid reversal
agents to prevent opioid-related
deaths due to overdoserdquo
wwwpharmacistcompolicycontrolled-substances-and-
other-medications-potential-abuse-and-use-opioid-
reversal-agents-2
Overdose education and naloxone distribution is
a key tool in addressing the overdose crisis
ASAM Board of Directors April 2010
ldquoNaloxone has been proven to be an effective fast-acting inexpensive and non-addictive opioid antagonist with minimal side effects Naloxone can be administered quickly and effectively by trained professional and lay individuals who observe the initial signs of an opioid overdose reactionrdquo
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
Naloxone Basics
21
Patients can go back into overdose if long acting opioids were taken
(fentanyl patch methadone extended release morphine extended release oxycodone)
Patients should avoid taking more opioids after naloxone administration so they do not go back into overdose after naloxone wears off
Patients may want to take more opioids during this time because they may feel withdrawal symptoms
Wears off in 30 - 90 minutes
Store at room temperature to minimize degradation
Shelf-life is 12-24 months
If patient is not responding in this time a second dose may need be administered
Takes effect in 2 - 3 minutes
21
Naloxone Formulations
Intranasal with atomizer attachment Auto-Injector
Intranasal spray Intramuscular injection
Rationale for Overdose Education
and Naloxone Rescue Kits bull Most people who use opioids do not use
alone
bull Known risk factors
Mixing substances loss of opioid
tolerance using alone unknown
source
bull Opportunity window
Opioid overdoses take minutes to hours
and is reversible with naloxone
Fentanyl reduces the window to seconds
to minutes
bull Bystanders are trainable to
recognize and respond to overdoses
bull Fear of public safety 23
Evaluations of Overdose Education and Naloxone Distribution Programs
24
Feasibility
bull Piper et al Subst Use Misuse 2008 43 858-70 bull Doe-Simkins et al Am J Public Health 2009 99 788-791 bull Enteen et al J Urban Health 201087 931-41 bull Bennett et al J Urban Health 2011 88 1020-30 bull Walley et al JSAT 2013 44241-7 (Methadone and detox programs)
Increased knowledge and skills
bull Green et al Addiction 2008 103979-89 bull Tobin et al Int J Drug Policy 2009 20 131-6 bull Wagner et al Int J Drug Policy 2010 21 186-93
No increase in use increase in drug
treatment
bull Seal et al J Urban Health 200582303-11 bull Doe-Simkins et al BMC Public Health 2014 14297 bull Jones et al Addictive Behaviors 201771104-6
Reduction in overdose in communities
bull Maxwell et al J Addict Dis 200625 89-96 bull Evans et al Am J Epidemiol 2012 174 302-8 bull Walley et al BMJ 2013 346 f174 bull Bird et al Addiction 2015 Dec 1 bull Coffin et al Ann Intern Med 2016 1-8
Cost-effective
$438 (best) to $14000 (worst ) per quality-
adjusted life year gained
bull Coffin and Sullivan Ann Intern Med 2013 Jan 1158(1)1-9
25
Objective Determine the impact of
opioid overdose education with
intranasal naloxone distribution
(OEND) programs on fatal and non-
fatal opioid overdose rates in
Massachusetts
Walley et al BMJ 2013 346 f174
INPEDE OD (Intranasal Naloxone and Prevention Educationrsquos Effect on
Overdose Study)
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
26
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
OEND programs 2006-07
27
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
28
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
29
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
Towns without
30
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
Fatal Opioid Overdose Rates by
OEND Implementation
31
Cumulative enrollments per 100k RR ARR 95 CI
Absolute model
No enrollment Ref Ref Ref
Low implementation 1-100 093 073 057-091
High implementation gt 100 082 054 039-076
Adjusted Rate Ratios (ARR) All rate ratios adjusted for the citytown
population rates of age under 18 male race ethnicity (hispanic white black other) below poverty level medically supervised
inpatient withdrawal treatment methadone treatment BSAS-funded buprenorphine treatment prescriptions to doctor shoppers and
year
Walley et al BMJ 2013 346 f174
Naloxone coverage per 100K
0
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
Opioid overdose death rate
27 reduction
32
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three
Years NYT ndash The UpShot 922017
Fentanyl is Driving Overdose Surge
12
13
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
14
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
15
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
16
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
17
Boston Globe ndash December 27 2015
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
18
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
Public health response to address overdoses related to illicitly made fentanyl
1 Fentanyl should be included on standard toxicology screens
2 Adapt existing harm reduction strategies such as direct observation of anyone using illicit
opioids and ensuring bystanders are equipped with naloxone
3 Enhanced access and linkage to medication for opioid use disorders
ldquoSo now what they [people selling illicit drugs] are doing is theyrsquore cutting the heroin with the fentanyl to make it stronger
And the dope [heroin] is so strong with the fentanyl in it that you get the whole dose of the fentanyl at once rather than
being time-released [like the patch] And thatrsquos why people are dyingmdashplain and simple You know they [people using
illicit drugs] are doing the whole bag [of heroin mixed with fentanyl] and they donrsquot realize that they canrsquot handle it their
body cant handle itrdquo -- Overdose bystander
Strategies to Address Fentanyl
Overdose Deaths
19
ldquoThe AMA has been a longtime supporter of increasing the availability of Naloxone for patients first responders and bystanders who can help save lives and has provided resources to bolster legislative efforts to increase access to this medication in several statesrdquo
wwwama-assnorgamapubnewsnews20142014-04-
07-naxolene-product-approvalpage
ldquoAPhA supports the pharmacistrsquos
role in selecting appropriate therapy
and dosing and initiating and
providing education about the
proper use of opioid reversal
agents to prevent opioid-related
deaths due to overdoserdquo
wwwpharmacistcompolicycontrolled-substances-and-
other-medications-potential-abuse-and-use-opioid-
reversal-agents-2
Overdose education and naloxone distribution is
a key tool in addressing the overdose crisis
ASAM Board of Directors April 2010
ldquoNaloxone has been proven to be an effective fast-acting inexpensive and non-addictive opioid antagonist with minimal side effects Naloxone can be administered quickly and effectively by trained professional and lay individuals who observe the initial signs of an opioid overdose reactionrdquo
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
Naloxone Basics
21
Patients can go back into overdose if long acting opioids were taken
(fentanyl patch methadone extended release morphine extended release oxycodone)
Patients should avoid taking more opioids after naloxone administration so they do not go back into overdose after naloxone wears off
Patients may want to take more opioids during this time because they may feel withdrawal symptoms
Wears off in 30 - 90 minutes
Store at room temperature to minimize degradation
Shelf-life is 12-24 months
If patient is not responding in this time a second dose may need be administered
Takes effect in 2 - 3 minutes
21
Naloxone Formulations
Intranasal with atomizer attachment Auto-Injector
Intranasal spray Intramuscular injection
Rationale for Overdose Education
and Naloxone Rescue Kits bull Most people who use opioids do not use
alone
bull Known risk factors
Mixing substances loss of opioid
tolerance using alone unknown
source
bull Opportunity window
Opioid overdoses take minutes to hours
and is reversible with naloxone
Fentanyl reduces the window to seconds
to minutes
bull Bystanders are trainable to
recognize and respond to overdoses
bull Fear of public safety 23
Evaluations of Overdose Education and Naloxone Distribution Programs
24
Feasibility
bull Piper et al Subst Use Misuse 2008 43 858-70 bull Doe-Simkins et al Am J Public Health 2009 99 788-791 bull Enteen et al J Urban Health 201087 931-41 bull Bennett et al J Urban Health 2011 88 1020-30 bull Walley et al JSAT 2013 44241-7 (Methadone and detox programs)
Increased knowledge and skills
bull Green et al Addiction 2008 103979-89 bull Tobin et al Int J Drug Policy 2009 20 131-6 bull Wagner et al Int J Drug Policy 2010 21 186-93
No increase in use increase in drug
treatment
bull Seal et al J Urban Health 200582303-11 bull Doe-Simkins et al BMC Public Health 2014 14297 bull Jones et al Addictive Behaviors 201771104-6
Reduction in overdose in communities
bull Maxwell et al J Addict Dis 200625 89-96 bull Evans et al Am J Epidemiol 2012 174 302-8 bull Walley et al BMJ 2013 346 f174 bull Bird et al Addiction 2015 Dec 1 bull Coffin et al Ann Intern Med 2016 1-8
Cost-effective
$438 (best) to $14000 (worst ) per quality-
adjusted life year gained
bull Coffin and Sullivan Ann Intern Med 2013 Jan 1158(1)1-9
25
Objective Determine the impact of
opioid overdose education with
intranasal naloxone distribution
(OEND) programs on fatal and non-
fatal opioid overdose rates in
Massachusetts
Walley et al BMJ 2013 346 f174
INPEDE OD (Intranasal Naloxone and Prevention Educationrsquos Effect on
Overdose Study)
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
26
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
OEND programs 2006-07
27
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
28
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
29
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
Towns without
30
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
Fatal Opioid Overdose Rates by
OEND Implementation
31
Cumulative enrollments per 100k RR ARR 95 CI
Absolute model
No enrollment Ref Ref Ref
Low implementation 1-100 093 073 057-091
High implementation gt 100 082 054 039-076
Adjusted Rate Ratios (ARR) All rate ratios adjusted for the citytown
population rates of age under 18 male race ethnicity (hispanic white black other) below poverty level medically supervised
inpatient withdrawal treatment methadone treatment BSAS-funded buprenorphine treatment prescriptions to doctor shoppers and
year
Walley et al BMJ 2013 346 f174
Naloxone coverage per 100K
0
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
Opioid overdose death rate
27 reduction
32
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
13
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
14
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
15
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
16
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
17
Boston Globe ndash December 27 2015
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
18
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
Public health response to address overdoses related to illicitly made fentanyl
1 Fentanyl should be included on standard toxicology screens
2 Adapt existing harm reduction strategies such as direct observation of anyone using illicit
opioids and ensuring bystanders are equipped with naloxone
3 Enhanced access and linkage to medication for opioid use disorders
ldquoSo now what they [people selling illicit drugs] are doing is theyrsquore cutting the heroin with the fentanyl to make it stronger
And the dope [heroin] is so strong with the fentanyl in it that you get the whole dose of the fentanyl at once rather than
being time-released [like the patch] And thatrsquos why people are dyingmdashplain and simple You know they [people using
illicit drugs] are doing the whole bag [of heroin mixed with fentanyl] and they donrsquot realize that they canrsquot handle it their
body cant handle itrdquo -- Overdose bystander
Strategies to Address Fentanyl
Overdose Deaths
19
ldquoThe AMA has been a longtime supporter of increasing the availability of Naloxone for patients first responders and bystanders who can help save lives and has provided resources to bolster legislative efforts to increase access to this medication in several statesrdquo
wwwama-assnorgamapubnewsnews20142014-04-
07-naxolene-product-approvalpage
ldquoAPhA supports the pharmacistrsquos
role in selecting appropriate therapy
and dosing and initiating and
providing education about the
proper use of opioid reversal
agents to prevent opioid-related
deaths due to overdoserdquo
wwwpharmacistcompolicycontrolled-substances-and-
other-medications-potential-abuse-and-use-opioid-
reversal-agents-2
Overdose education and naloxone distribution is
a key tool in addressing the overdose crisis
ASAM Board of Directors April 2010
ldquoNaloxone has been proven to be an effective fast-acting inexpensive and non-addictive opioid antagonist with minimal side effects Naloxone can be administered quickly and effectively by trained professional and lay individuals who observe the initial signs of an opioid overdose reactionrdquo
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
Naloxone Basics
21
Patients can go back into overdose if long acting opioids were taken
(fentanyl patch methadone extended release morphine extended release oxycodone)
Patients should avoid taking more opioids after naloxone administration so they do not go back into overdose after naloxone wears off
Patients may want to take more opioids during this time because they may feel withdrawal symptoms
Wears off in 30 - 90 minutes
Store at room temperature to minimize degradation
Shelf-life is 12-24 months
If patient is not responding in this time a second dose may need be administered
Takes effect in 2 - 3 minutes
21
Naloxone Formulations
Intranasal with atomizer attachment Auto-Injector
Intranasal spray Intramuscular injection
Rationale for Overdose Education
and Naloxone Rescue Kits bull Most people who use opioids do not use
alone
bull Known risk factors
Mixing substances loss of opioid
tolerance using alone unknown
source
bull Opportunity window
Opioid overdoses take minutes to hours
and is reversible with naloxone
Fentanyl reduces the window to seconds
to minutes
bull Bystanders are trainable to
recognize and respond to overdoses
bull Fear of public safety 23
Evaluations of Overdose Education and Naloxone Distribution Programs
24
Feasibility
bull Piper et al Subst Use Misuse 2008 43 858-70 bull Doe-Simkins et al Am J Public Health 2009 99 788-791 bull Enteen et al J Urban Health 201087 931-41 bull Bennett et al J Urban Health 2011 88 1020-30 bull Walley et al JSAT 2013 44241-7 (Methadone and detox programs)
Increased knowledge and skills
bull Green et al Addiction 2008 103979-89 bull Tobin et al Int J Drug Policy 2009 20 131-6 bull Wagner et al Int J Drug Policy 2010 21 186-93
No increase in use increase in drug
treatment
bull Seal et al J Urban Health 200582303-11 bull Doe-Simkins et al BMC Public Health 2014 14297 bull Jones et al Addictive Behaviors 201771104-6
Reduction in overdose in communities
bull Maxwell et al J Addict Dis 200625 89-96 bull Evans et al Am J Epidemiol 2012 174 302-8 bull Walley et al BMJ 2013 346 f174 bull Bird et al Addiction 2015 Dec 1 bull Coffin et al Ann Intern Med 2016 1-8
Cost-effective
$438 (best) to $14000 (worst ) per quality-
adjusted life year gained
bull Coffin and Sullivan Ann Intern Med 2013 Jan 1158(1)1-9
25
Objective Determine the impact of
opioid overdose education with
intranasal naloxone distribution
(OEND) programs on fatal and non-
fatal opioid overdose rates in
Massachusetts
Walley et al BMJ 2013 346 f174
INPEDE OD (Intranasal Naloxone and Prevention Educationrsquos Effect on
Overdose Study)
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
26
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
OEND programs 2006-07
27
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
28
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
29
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
Towns without
30
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
Fatal Opioid Overdose Rates by
OEND Implementation
31
Cumulative enrollments per 100k RR ARR 95 CI
Absolute model
No enrollment Ref Ref Ref
Low implementation 1-100 093 073 057-091
High implementation gt 100 082 054 039-076
Adjusted Rate Ratios (ARR) All rate ratios adjusted for the citytown
population rates of age under 18 male race ethnicity (hispanic white black other) below poverty level medically supervised
inpatient withdrawal treatment methadone treatment BSAS-funded buprenorphine treatment prescriptions to doctor shoppers and
year
Walley et al BMJ 2013 346 f174
Naloxone coverage per 100K
0
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
Opioid overdose death rate
27 reduction
32
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
14
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
15
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
16
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
17
Boston Globe ndash December 27 2015
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
18
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
Public health response to address overdoses related to illicitly made fentanyl
1 Fentanyl should be included on standard toxicology screens
2 Adapt existing harm reduction strategies such as direct observation of anyone using illicit
opioids and ensuring bystanders are equipped with naloxone
3 Enhanced access and linkage to medication for opioid use disorders
ldquoSo now what they [people selling illicit drugs] are doing is theyrsquore cutting the heroin with the fentanyl to make it stronger
And the dope [heroin] is so strong with the fentanyl in it that you get the whole dose of the fentanyl at once rather than
being time-released [like the patch] And thatrsquos why people are dyingmdashplain and simple You know they [people using
illicit drugs] are doing the whole bag [of heroin mixed with fentanyl] and they donrsquot realize that they canrsquot handle it their
body cant handle itrdquo -- Overdose bystander
Strategies to Address Fentanyl
Overdose Deaths
19
ldquoThe AMA has been a longtime supporter of increasing the availability of Naloxone for patients first responders and bystanders who can help save lives and has provided resources to bolster legislative efforts to increase access to this medication in several statesrdquo
wwwama-assnorgamapubnewsnews20142014-04-
07-naxolene-product-approvalpage
ldquoAPhA supports the pharmacistrsquos
role in selecting appropriate therapy
and dosing and initiating and
providing education about the
proper use of opioid reversal
agents to prevent opioid-related
deaths due to overdoserdquo
wwwpharmacistcompolicycontrolled-substances-and-
other-medications-potential-abuse-and-use-opioid-
reversal-agents-2
Overdose education and naloxone distribution is
a key tool in addressing the overdose crisis
ASAM Board of Directors April 2010
ldquoNaloxone has been proven to be an effective fast-acting inexpensive and non-addictive opioid antagonist with minimal side effects Naloxone can be administered quickly and effectively by trained professional and lay individuals who observe the initial signs of an opioid overdose reactionrdquo
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
Naloxone Basics
21
Patients can go back into overdose if long acting opioids were taken
(fentanyl patch methadone extended release morphine extended release oxycodone)
Patients should avoid taking more opioids after naloxone administration so they do not go back into overdose after naloxone wears off
Patients may want to take more opioids during this time because they may feel withdrawal symptoms
Wears off in 30 - 90 minutes
Store at room temperature to minimize degradation
Shelf-life is 12-24 months
If patient is not responding in this time a second dose may need be administered
Takes effect in 2 - 3 minutes
21
Naloxone Formulations
Intranasal with atomizer attachment Auto-Injector
Intranasal spray Intramuscular injection
Rationale for Overdose Education
and Naloxone Rescue Kits bull Most people who use opioids do not use
alone
bull Known risk factors
Mixing substances loss of opioid
tolerance using alone unknown
source
bull Opportunity window
Opioid overdoses take minutes to hours
and is reversible with naloxone
Fentanyl reduces the window to seconds
to minutes
bull Bystanders are trainable to
recognize and respond to overdoses
bull Fear of public safety 23
Evaluations of Overdose Education and Naloxone Distribution Programs
24
Feasibility
bull Piper et al Subst Use Misuse 2008 43 858-70 bull Doe-Simkins et al Am J Public Health 2009 99 788-791 bull Enteen et al J Urban Health 201087 931-41 bull Bennett et al J Urban Health 2011 88 1020-30 bull Walley et al JSAT 2013 44241-7 (Methadone and detox programs)
Increased knowledge and skills
bull Green et al Addiction 2008 103979-89 bull Tobin et al Int J Drug Policy 2009 20 131-6 bull Wagner et al Int J Drug Policy 2010 21 186-93
No increase in use increase in drug
treatment
bull Seal et al J Urban Health 200582303-11 bull Doe-Simkins et al BMC Public Health 2014 14297 bull Jones et al Addictive Behaviors 201771104-6
Reduction in overdose in communities
bull Maxwell et al J Addict Dis 200625 89-96 bull Evans et al Am J Epidemiol 2012 174 302-8 bull Walley et al BMJ 2013 346 f174 bull Bird et al Addiction 2015 Dec 1 bull Coffin et al Ann Intern Med 2016 1-8
Cost-effective
$438 (best) to $14000 (worst ) per quality-
adjusted life year gained
bull Coffin and Sullivan Ann Intern Med 2013 Jan 1158(1)1-9
25
Objective Determine the impact of
opioid overdose education with
intranasal naloxone distribution
(OEND) programs on fatal and non-
fatal opioid overdose rates in
Massachusetts
Walley et al BMJ 2013 346 f174
INPEDE OD (Intranasal Naloxone and Prevention Educationrsquos Effect on
Overdose Study)
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
26
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
OEND programs 2006-07
27
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
28
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
29
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
Towns without
30
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
Fatal Opioid Overdose Rates by
OEND Implementation
31
Cumulative enrollments per 100k RR ARR 95 CI
Absolute model
No enrollment Ref Ref Ref
Low implementation 1-100 093 073 057-091
High implementation gt 100 082 054 039-076
Adjusted Rate Ratios (ARR) All rate ratios adjusted for the citytown
population rates of age under 18 male race ethnicity (hispanic white black other) below poverty level medically supervised
inpatient withdrawal treatment methadone treatment BSAS-funded buprenorphine treatment prescriptions to doctor shoppers and
year
Walley et al BMJ 2013 346 f174
Naloxone coverage per 100K
0
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
Opioid overdose death rate
27 reduction
32
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
15
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
16
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
17
Boston Globe ndash December 27 2015
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
18
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
Public health response to address overdoses related to illicitly made fentanyl
1 Fentanyl should be included on standard toxicology screens
2 Adapt existing harm reduction strategies such as direct observation of anyone using illicit
opioids and ensuring bystanders are equipped with naloxone
3 Enhanced access and linkage to medication for opioid use disorders
ldquoSo now what they [people selling illicit drugs] are doing is theyrsquore cutting the heroin with the fentanyl to make it stronger
And the dope [heroin] is so strong with the fentanyl in it that you get the whole dose of the fentanyl at once rather than
being time-released [like the patch] And thatrsquos why people are dyingmdashplain and simple You know they [people using
illicit drugs] are doing the whole bag [of heroin mixed with fentanyl] and they donrsquot realize that they canrsquot handle it their
body cant handle itrdquo -- Overdose bystander
Strategies to Address Fentanyl
Overdose Deaths
19
ldquoThe AMA has been a longtime supporter of increasing the availability of Naloxone for patients first responders and bystanders who can help save lives and has provided resources to bolster legislative efforts to increase access to this medication in several statesrdquo
wwwama-assnorgamapubnewsnews20142014-04-
07-naxolene-product-approvalpage
ldquoAPhA supports the pharmacistrsquos
role in selecting appropriate therapy
and dosing and initiating and
providing education about the
proper use of opioid reversal
agents to prevent opioid-related
deaths due to overdoserdquo
wwwpharmacistcompolicycontrolled-substances-and-
other-medications-potential-abuse-and-use-opioid-
reversal-agents-2
Overdose education and naloxone distribution is
a key tool in addressing the overdose crisis
ASAM Board of Directors April 2010
ldquoNaloxone has been proven to be an effective fast-acting inexpensive and non-addictive opioid antagonist with minimal side effects Naloxone can be administered quickly and effectively by trained professional and lay individuals who observe the initial signs of an opioid overdose reactionrdquo
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
Naloxone Basics
21
Patients can go back into overdose if long acting opioids were taken
(fentanyl patch methadone extended release morphine extended release oxycodone)
Patients should avoid taking more opioids after naloxone administration so they do not go back into overdose after naloxone wears off
Patients may want to take more opioids during this time because they may feel withdrawal symptoms
Wears off in 30 - 90 minutes
Store at room temperature to minimize degradation
Shelf-life is 12-24 months
If patient is not responding in this time a second dose may need be administered
Takes effect in 2 - 3 minutes
21
Naloxone Formulations
Intranasal with atomizer attachment Auto-Injector
Intranasal spray Intramuscular injection
Rationale for Overdose Education
and Naloxone Rescue Kits bull Most people who use opioids do not use
alone
bull Known risk factors
Mixing substances loss of opioid
tolerance using alone unknown
source
bull Opportunity window
Opioid overdoses take minutes to hours
and is reversible with naloxone
Fentanyl reduces the window to seconds
to minutes
bull Bystanders are trainable to
recognize and respond to overdoses
bull Fear of public safety 23
Evaluations of Overdose Education and Naloxone Distribution Programs
24
Feasibility
bull Piper et al Subst Use Misuse 2008 43 858-70 bull Doe-Simkins et al Am J Public Health 2009 99 788-791 bull Enteen et al J Urban Health 201087 931-41 bull Bennett et al J Urban Health 2011 88 1020-30 bull Walley et al JSAT 2013 44241-7 (Methadone and detox programs)
Increased knowledge and skills
bull Green et al Addiction 2008 103979-89 bull Tobin et al Int J Drug Policy 2009 20 131-6 bull Wagner et al Int J Drug Policy 2010 21 186-93
No increase in use increase in drug
treatment
bull Seal et al J Urban Health 200582303-11 bull Doe-Simkins et al BMC Public Health 2014 14297 bull Jones et al Addictive Behaviors 201771104-6
Reduction in overdose in communities
bull Maxwell et al J Addict Dis 200625 89-96 bull Evans et al Am J Epidemiol 2012 174 302-8 bull Walley et al BMJ 2013 346 f174 bull Bird et al Addiction 2015 Dec 1 bull Coffin et al Ann Intern Med 2016 1-8
Cost-effective
$438 (best) to $14000 (worst ) per quality-
adjusted life year gained
bull Coffin and Sullivan Ann Intern Med 2013 Jan 1158(1)1-9
25
Objective Determine the impact of
opioid overdose education with
intranasal naloxone distribution
(OEND) programs on fatal and non-
fatal opioid overdose rates in
Massachusetts
Walley et al BMJ 2013 346 f174
INPEDE OD (Intranasal Naloxone and Prevention Educationrsquos Effect on
Overdose Study)
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
26
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
OEND programs 2006-07
27
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
28
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
29
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
Towns without
30
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
Fatal Opioid Overdose Rates by
OEND Implementation
31
Cumulative enrollments per 100k RR ARR 95 CI
Absolute model
No enrollment Ref Ref Ref
Low implementation 1-100 093 073 057-091
High implementation gt 100 082 054 039-076
Adjusted Rate Ratios (ARR) All rate ratios adjusted for the citytown
population rates of age under 18 male race ethnicity (hispanic white black other) below poverty level medically supervised
inpatient withdrawal treatment methadone treatment BSAS-funded buprenorphine treatment prescriptions to doctor shoppers and
year
Walley et al BMJ 2013 346 f174
Naloxone coverage per 100K
0
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
Opioid overdose death rate
27 reduction
32
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
16
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
17
Boston Globe ndash December 27 2015
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
18
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
Public health response to address overdoses related to illicitly made fentanyl
1 Fentanyl should be included on standard toxicology screens
2 Adapt existing harm reduction strategies such as direct observation of anyone using illicit
opioids and ensuring bystanders are equipped with naloxone
3 Enhanced access and linkage to medication for opioid use disorders
ldquoSo now what they [people selling illicit drugs] are doing is theyrsquore cutting the heroin with the fentanyl to make it stronger
And the dope [heroin] is so strong with the fentanyl in it that you get the whole dose of the fentanyl at once rather than
being time-released [like the patch] And thatrsquos why people are dyingmdashplain and simple You know they [people using
illicit drugs] are doing the whole bag [of heroin mixed with fentanyl] and they donrsquot realize that they canrsquot handle it their
body cant handle itrdquo -- Overdose bystander
Strategies to Address Fentanyl
Overdose Deaths
19
ldquoThe AMA has been a longtime supporter of increasing the availability of Naloxone for patients first responders and bystanders who can help save lives and has provided resources to bolster legislative efforts to increase access to this medication in several statesrdquo
wwwama-assnorgamapubnewsnews20142014-04-
07-naxolene-product-approvalpage
ldquoAPhA supports the pharmacistrsquos
role in selecting appropriate therapy
and dosing and initiating and
providing education about the
proper use of opioid reversal
agents to prevent opioid-related
deaths due to overdoserdquo
wwwpharmacistcompolicycontrolled-substances-and-
other-medications-potential-abuse-and-use-opioid-
reversal-agents-2
Overdose education and naloxone distribution is
a key tool in addressing the overdose crisis
ASAM Board of Directors April 2010
ldquoNaloxone has been proven to be an effective fast-acting inexpensive and non-addictive opioid antagonist with minimal side effects Naloxone can be administered quickly and effectively by trained professional and lay individuals who observe the initial signs of an opioid overdose reactionrdquo
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
Naloxone Basics
21
Patients can go back into overdose if long acting opioids were taken
(fentanyl patch methadone extended release morphine extended release oxycodone)
Patients should avoid taking more opioids after naloxone administration so they do not go back into overdose after naloxone wears off
Patients may want to take more opioids during this time because they may feel withdrawal symptoms
Wears off in 30 - 90 minutes
Store at room temperature to minimize degradation
Shelf-life is 12-24 months
If patient is not responding in this time a second dose may need be administered
Takes effect in 2 - 3 minutes
21
Naloxone Formulations
Intranasal with atomizer attachment Auto-Injector
Intranasal spray Intramuscular injection
Rationale for Overdose Education
and Naloxone Rescue Kits bull Most people who use opioids do not use
alone
bull Known risk factors
Mixing substances loss of opioid
tolerance using alone unknown
source
bull Opportunity window
Opioid overdoses take minutes to hours
and is reversible with naloxone
Fentanyl reduces the window to seconds
to minutes
bull Bystanders are trainable to
recognize and respond to overdoses
bull Fear of public safety 23
Evaluations of Overdose Education and Naloxone Distribution Programs
24
Feasibility
bull Piper et al Subst Use Misuse 2008 43 858-70 bull Doe-Simkins et al Am J Public Health 2009 99 788-791 bull Enteen et al J Urban Health 201087 931-41 bull Bennett et al J Urban Health 2011 88 1020-30 bull Walley et al JSAT 2013 44241-7 (Methadone and detox programs)
Increased knowledge and skills
bull Green et al Addiction 2008 103979-89 bull Tobin et al Int J Drug Policy 2009 20 131-6 bull Wagner et al Int J Drug Policy 2010 21 186-93
No increase in use increase in drug
treatment
bull Seal et al J Urban Health 200582303-11 bull Doe-Simkins et al BMC Public Health 2014 14297 bull Jones et al Addictive Behaviors 201771104-6
Reduction in overdose in communities
bull Maxwell et al J Addict Dis 200625 89-96 bull Evans et al Am J Epidemiol 2012 174 302-8 bull Walley et al BMJ 2013 346 f174 bull Bird et al Addiction 2015 Dec 1 bull Coffin et al Ann Intern Med 2016 1-8
Cost-effective
$438 (best) to $14000 (worst ) per quality-
adjusted life year gained
bull Coffin and Sullivan Ann Intern Med 2013 Jan 1158(1)1-9
25
Objective Determine the impact of
opioid overdose education with
intranasal naloxone distribution
(OEND) programs on fatal and non-
fatal opioid overdose rates in
Massachusetts
Walley et al BMJ 2013 346 f174
INPEDE OD (Intranasal Naloxone and Prevention Educationrsquos Effect on
Overdose Study)
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
26
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
OEND programs 2006-07
27
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
28
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
29
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
Towns without
30
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
Fatal Opioid Overdose Rates by
OEND Implementation
31
Cumulative enrollments per 100k RR ARR 95 CI
Absolute model
No enrollment Ref Ref Ref
Low implementation 1-100 093 073 057-091
High implementation gt 100 082 054 039-076
Adjusted Rate Ratios (ARR) All rate ratios adjusted for the citytown
population rates of age under 18 male race ethnicity (hispanic white black other) below poverty level medically supervised
inpatient withdrawal treatment methadone treatment BSAS-funded buprenorphine treatment prescriptions to doctor shoppers and
year
Walley et al BMJ 2013 346 f174
Naloxone coverage per 100K
0
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
Opioid overdose death rate
27 reduction
32
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
17
Boston Globe ndash December 27 2015
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
18
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
Public health response to address overdoses related to illicitly made fentanyl
1 Fentanyl should be included on standard toxicology screens
2 Adapt existing harm reduction strategies such as direct observation of anyone using illicit
opioids and ensuring bystanders are equipped with naloxone
3 Enhanced access and linkage to medication for opioid use disorders
ldquoSo now what they [people selling illicit drugs] are doing is theyrsquore cutting the heroin with the fentanyl to make it stronger
And the dope [heroin] is so strong with the fentanyl in it that you get the whole dose of the fentanyl at once rather than
being time-released [like the patch] And thatrsquos why people are dyingmdashplain and simple You know they [people using
illicit drugs] are doing the whole bag [of heroin mixed with fentanyl] and they donrsquot realize that they canrsquot handle it their
body cant handle itrdquo -- Overdose bystander
Strategies to Address Fentanyl
Overdose Deaths
19
ldquoThe AMA has been a longtime supporter of increasing the availability of Naloxone for patients first responders and bystanders who can help save lives and has provided resources to bolster legislative efforts to increase access to this medication in several statesrdquo
wwwama-assnorgamapubnewsnews20142014-04-
07-naxolene-product-approvalpage
ldquoAPhA supports the pharmacistrsquos
role in selecting appropriate therapy
and dosing and initiating and
providing education about the
proper use of opioid reversal
agents to prevent opioid-related
deaths due to overdoserdquo
wwwpharmacistcompolicycontrolled-substances-and-
other-medications-potential-abuse-and-use-opioid-
reversal-agents-2
Overdose education and naloxone distribution is
a key tool in addressing the overdose crisis
ASAM Board of Directors April 2010
ldquoNaloxone has been proven to be an effective fast-acting inexpensive and non-addictive opioid antagonist with minimal side effects Naloxone can be administered quickly and effectively by trained professional and lay individuals who observe the initial signs of an opioid overdose reactionrdquo
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
Naloxone Basics
21
Patients can go back into overdose if long acting opioids were taken
(fentanyl patch methadone extended release morphine extended release oxycodone)
Patients should avoid taking more opioids after naloxone administration so they do not go back into overdose after naloxone wears off
Patients may want to take more opioids during this time because they may feel withdrawal symptoms
Wears off in 30 - 90 minutes
Store at room temperature to minimize degradation
Shelf-life is 12-24 months
If patient is not responding in this time a second dose may need be administered
Takes effect in 2 - 3 minutes
21
Naloxone Formulations
Intranasal with atomizer attachment Auto-Injector
Intranasal spray Intramuscular injection
Rationale for Overdose Education
and Naloxone Rescue Kits bull Most people who use opioids do not use
alone
bull Known risk factors
Mixing substances loss of opioid
tolerance using alone unknown
source
bull Opportunity window
Opioid overdoses take minutes to hours
and is reversible with naloxone
Fentanyl reduces the window to seconds
to minutes
bull Bystanders are trainable to
recognize and respond to overdoses
bull Fear of public safety 23
Evaluations of Overdose Education and Naloxone Distribution Programs
24
Feasibility
bull Piper et al Subst Use Misuse 2008 43 858-70 bull Doe-Simkins et al Am J Public Health 2009 99 788-791 bull Enteen et al J Urban Health 201087 931-41 bull Bennett et al J Urban Health 2011 88 1020-30 bull Walley et al JSAT 2013 44241-7 (Methadone and detox programs)
Increased knowledge and skills
bull Green et al Addiction 2008 103979-89 bull Tobin et al Int J Drug Policy 2009 20 131-6 bull Wagner et al Int J Drug Policy 2010 21 186-93
No increase in use increase in drug
treatment
bull Seal et al J Urban Health 200582303-11 bull Doe-Simkins et al BMC Public Health 2014 14297 bull Jones et al Addictive Behaviors 201771104-6
Reduction in overdose in communities
bull Maxwell et al J Addict Dis 200625 89-96 bull Evans et al Am J Epidemiol 2012 174 302-8 bull Walley et al BMJ 2013 346 f174 bull Bird et al Addiction 2015 Dec 1 bull Coffin et al Ann Intern Med 2016 1-8
Cost-effective
$438 (best) to $14000 (worst ) per quality-
adjusted life year gained
bull Coffin and Sullivan Ann Intern Med 2013 Jan 1158(1)1-9
25
Objective Determine the impact of
opioid overdose education with
intranasal naloxone distribution
(OEND) programs on fatal and non-
fatal opioid overdose rates in
Massachusetts
Walley et al BMJ 2013 346 f174
INPEDE OD (Intranasal Naloxone and Prevention Educationrsquos Effect on
Overdose Study)
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
26
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
OEND programs 2006-07
27
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
28
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
29
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
Towns without
30
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
Fatal Opioid Overdose Rates by
OEND Implementation
31
Cumulative enrollments per 100k RR ARR 95 CI
Absolute model
No enrollment Ref Ref Ref
Low implementation 1-100 093 073 057-091
High implementation gt 100 082 054 039-076
Adjusted Rate Ratios (ARR) All rate ratios adjusted for the citytown
population rates of age under 18 male race ethnicity (hispanic white black other) below poverty level medically supervised
inpatient withdrawal treatment methadone treatment BSAS-funded buprenorphine treatment prescriptions to doctor shoppers and
year
Walley et al BMJ 2013 346 f174
Naloxone coverage per 100K
0
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
Opioid overdose death rate
27 reduction
32
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
18
Strategies to Address Overdose
bull Prescription monitoring programs
Delcher et al DAD 2015 150 63-68
bull Prescription drug safe storage and disposal
Gray et al Arch Intern Med 2012 172 1186-87
bull Safe opioid prescribing education
Alford et al Pain Med 2015 17(1)52-63
bull Medication for opioid use disorders
Sordo et al BMJ 2017 357j1550
bull Supervised injection facilities
Marshall et al Lancet 20113771429-37
bull Overdose Education and Naloxone Distribution
Public health response to address overdoses related to illicitly made fentanyl
1 Fentanyl should be included on standard toxicology screens
2 Adapt existing harm reduction strategies such as direct observation of anyone using illicit
opioids and ensuring bystanders are equipped with naloxone
3 Enhanced access and linkage to medication for opioid use disorders
ldquoSo now what they [people selling illicit drugs] are doing is theyrsquore cutting the heroin with the fentanyl to make it stronger
And the dope [heroin] is so strong with the fentanyl in it that you get the whole dose of the fentanyl at once rather than
being time-released [like the patch] And thatrsquos why people are dyingmdashplain and simple You know they [people using
illicit drugs] are doing the whole bag [of heroin mixed with fentanyl] and they donrsquot realize that they canrsquot handle it their
body cant handle itrdquo -- Overdose bystander
Strategies to Address Fentanyl
Overdose Deaths
19
ldquoThe AMA has been a longtime supporter of increasing the availability of Naloxone for patients first responders and bystanders who can help save lives and has provided resources to bolster legislative efforts to increase access to this medication in several statesrdquo
wwwama-assnorgamapubnewsnews20142014-04-
07-naxolene-product-approvalpage
ldquoAPhA supports the pharmacistrsquos
role in selecting appropriate therapy
and dosing and initiating and
providing education about the
proper use of opioid reversal
agents to prevent opioid-related
deaths due to overdoserdquo
wwwpharmacistcompolicycontrolled-substances-and-
other-medications-potential-abuse-and-use-opioid-
reversal-agents-2
Overdose education and naloxone distribution is
a key tool in addressing the overdose crisis
ASAM Board of Directors April 2010
ldquoNaloxone has been proven to be an effective fast-acting inexpensive and non-addictive opioid antagonist with minimal side effects Naloxone can be administered quickly and effectively by trained professional and lay individuals who observe the initial signs of an opioid overdose reactionrdquo
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
Naloxone Basics
21
Patients can go back into overdose if long acting opioids were taken
(fentanyl patch methadone extended release morphine extended release oxycodone)
Patients should avoid taking more opioids after naloxone administration so they do not go back into overdose after naloxone wears off
Patients may want to take more opioids during this time because they may feel withdrawal symptoms
Wears off in 30 - 90 minutes
Store at room temperature to minimize degradation
Shelf-life is 12-24 months
If patient is not responding in this time a second dose may need be administered
Takes effect in 2 - 3 minutes
21
Naloxone Formulations
Intranasal with atomizer attachment Auto-Injector
Intranasal spray Intramuscular injection
Rationale for Overdose Education
and Naloxone Rescue Kits bull Most people who use opioids do not use
alone
bull Known risk factors
Mixing substances loss of opioid
tolerance using alone unknown
source
bull Opportunity window
Opioid overdoses take minutes to hours
and is reversible with naloxone
Fentanyl reduces the window to seconds
to minutes
bull Bystanders are trainable to
recognize and respond to overdoses
bull Fear of public safety 23
Evaluations of Overdose Education and Naloxone Distribution Programs
24
Feasibility
bull Piper et al Subst Use Misuse 2008 43 858-70 bull Doe-Simkins et al Am J Public Health 2009 99 788-791 bull Enteen et al J Urban Health 201087 931-41 bull Bennett et al J Urban Health 2011 88 1020-30 bull Walley et al JSAT 2013 44241-7 (Methadone and detox programs)
Increased knowledge and skills
bull Green et al Addiction 2008 103979-89 bull Tobin et al Int J Drug Policy 2009 20 131-6 bull Wagner et al Int J Drug Policy 2010 21 186-93
No increase in use increase in drug
treatment
bull Seal et al J Urban Health 200582303-11 bull Doe-Simkins et al BMC Public Health 2014 14297 bull Jones et al Addictive Behaviors 201771104-6
Reduction in overdose in communities
bull Maxwell et al J Addict Dis 200625 89-96 bull Evans et al Am J Epidemiol 2012 174 302-8 bull Walley et al BMJ 2013 346 f174 bull Bird et al Addiction 2015 Dec 1 bull Coffin et al Ann Intern Med 2016 1-8
Cost-effective
$438 (best) to $14000 (worst ) per quality-
adjusted life year gained
bull Coffin and Sullivan Ann Intern Med 2013 Jan 1158(1)1-9
25
Objective Determine the impact of
opioid overdose education with
intranasal naloxone distribution
(OEND) programs on fatal and non-
fatal opioid overdose rates in
Massachusetts
Walley et al BMJ 2013 346 f174
INPEDE OD (Intranasal Naloxone and Prevention Educationrsquos Effect on
Overdose Study)
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
26
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
OEND programs 2006-07
27
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
28
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
29
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
Towns without
30
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
Fatal Opioid Overdose Rates by
OEND Implementation
31
Cumulative enrollments per 100k RR ARR 95 CI
Absolute model
No enrollment Ref Ref Ref
Low implementation 1-100 093 073 057-091
High implementation gt 100 082 054 039-076
Adjusted Rate Ratios (ARR) All rate ratios adjusted for the citytown
population rates of age under 18 male race ethnicity (hispanic white black other) below poverty level medically supervised
inpatient withdrawal treatment methadone treatment BSAS-funded buprenorphine treatment prescriptions to doctor shoppers and
year
Walley et al BMJ 2013 346 f174
Naloxone coverage per 100K
0
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
Opioid overdose death rate
27 reduction
32
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Public health response to address overdoses related to illicitly made fentanyl
1 Fentanyl should be included on standard toxicology screens
2 Adapt existing harm reduction strategies such as direct observation of anyone using illicit
opioids and ensuring bystanders are equipped with naloxone
3 Enhanced access and linkage to medication for opioid use disorders
ldquoSo now what they [people selling illicit drugs] are doing is theyrsquore cutting the heroin with the fentanyl to make it stronger
And the dope [heroin] is so strong with the fentanyl in it that you get the whole dose of the fentanyl at once rather than
being time-released [like the patch] And thatrsquos why people are dyingmdashplain and simple You know they [people using
illicit drugs] are doing the whole bag [of heroin mixed with fentanyl] and they donrsquot realize that they canrsquot handle it their
body cant handle itrdquo -- Overdose bystander
Strategies to Address Fentanyl
Overdose Deaths
19
ldquoThe AMA has been a longtime supporter of increasing the availability of Naloxone for patients first responders and bystanders who can help save lives and has provided resources to bolster legislative efforts to increase access to this medication in several statesrdquo
wwwama-assnorgamapubnewsnews20142014-04-
07-naxolene-product-approvalpage
ldquoAPhA supports the pharmacistrsquos
role in selecting appropriate therapy
and dosing and initiating and
providing education about the
proper use of opioid reversal
agents to prevent opioid-related
deaths due to overdoserdquo
wwwpharmacistcompolicycontrolled-substances-and-
other-medications-potential-abuse-and-use-opioid-
reversal-agents-2
Overdose education and naloxone distribution is
a key tool in addressing the overdose crisis
ASAM Board of Directors April 2010
ldquoNaloxone has been proven to be an effective fast-acting inexpensive and non-addictive opioid antagonist with minimal side effects Naloxone can be administered quickly and effectively by trained professional and lay individuals who observe the initial signs of an opioid overdose reactionrdquo
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
Naloxone Basics
21
Patients can go back into overdose if long acting opioids were taken
(fentanyl patch methadone extended release morphine extended release oxycodone)
Patients should avoid taking more opioids after naloxone administration so they do not go back into overdose after naloxone wears off
Patients may want to take more opioids during this time because they may feel withdrawal symptoms
Wears off in 30 - 90 minutes
Store at room temperature to minimize degradation
Shelf-life is 12-24 months
If patient is not responding in this time a second dose may need be administered
Takes effect in 2 - 3 minutes
21
Naloxone Formulations
Intranasal with atomizer attachment Auto-Injector
Intranasal spray Intramuscular injection
Rationale for Overdose Education
and Naloxone Rescue Kits bull Most people who use opioids do not use
alone
bull Known risk factors
Mixing substances loss of opioid
tolerance using alone unknown
source
bull Opportunity window
Opioid overdoses take minutes to hours
and is reversible with naloxone
Fentanyl reduces the window to seconds
to minutes
bull Bystanders are trainable to
recognize and respond to overdoses
bull Fear of public safety 23
Evaluations of Overdose Education and Naloxone Distribution Programs
24
Feasibility
bull Piper et al Subst Use Misuse 2008 43 858-70 bull Doe-Simkins et al Am J Public Health 2009 99 788-791 bull Enteen et al J Urban Health 201087 931-41 bull Bennett et al J Urban Health 2011 88 1020-30 bull Walley et al JSAT 2013 44241-7 (Methadone and detox programs)
Increased knowledge and skills
bull Green et al Addiction 2008 103979-89 bull Tobin et al Int J Drug Policy 2009 20 131-6 bull Wagner et al Int J Drug Policy 2010 21 186-93
No increase in use increase in drug
treatment
bull Seal et al J Urban Health 200582303-11 bull Doe-Simkins et al BMC Public Health 2014 14297 bull Jones et al Addictive Behaviors 201771104-6
Reduction in overdose in communities
bull Maxwell et al J Addict Dis 200625 89-96 bull Evans et al Am J Epidemiol 2012 174 302-8 bull Walley et al BMJ 2013 346 f174 bull Bird et al Addiction 2015 Dec 1 bull Coffin et al Ann Intern Med 2016 1-8
Cost-effective
$438 (best) to $14000 (worst ) per quality-
adjusted life year gained
bull Coffin and Sullivan Ann Intern Med 2013 Jan 1158(1)1-9
25
Objective Determine the impact of
opioid overdose education with
intranasal naloxone distribution
(OEND) programs on fatal and non-
fatal opioid overdose rates in
Massachusetts
Walley et al BMJ 2013 346 f174
INPEDE OD (Intranasal Naloxone and Prevention Educationrsquos Effect on
Overdose Study)
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
26
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
OEND programs 2006-07
27
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
28
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
29
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
Towns without
30
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
Fatal Opioid Overdose Rates by
OEND Implementation
31
Cumulative enrollments per 100k RR ARR 95 CI
Absolute model
No enrollment Ref Ref Ref
Low implementation 1-100 093 073 057-091
High implementation gt 100 082 054 039-076
Adjusted Rate Ratios (ARR) All rate ratios adjusted for the citytown
population rates of age under 18 male race ethnicity (hispanic white black other) below poverty level medically supervised
inpatient withdrawal treatment methadone treatment BSAS-funded buprenorphine treatment prescriptions to doctor shoppers and
year
Walley et al BMJ 2013 346 f174
Naloxone coverage per 100K
0
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
Opioid overdose death rate
27 reduction
32
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
ldquoThe AMA has been a longtime supporter of increasing the availability of Naloxone for patients first responders and bystanders who can help save lives and has provided resources to bolster legislative efforts to increase access to this medication in several statesrdquo
wwwama-assnorgamapubnewsnews20142014-04-
07-naxolene-product-approvalpage
ldquoAPhA supports the pharmacistrsquos
role in selecting appropriate therapy
and dosing and initiating and
providing education about the
proper use of opioid reversal
agents to prevent opioid-related
deaths due to overdoserdquo
wwwpharmacistcompolicycontrolled-substances-and-
other-medications-potential-abuse-and-use-opioid-
reversal-agents-2
Overdose education and naloxone distribution is
a key tool in addressing the overdose crisis
ASAM Board of Directors April 2010
ldquoNaloxone has been proven to be an effective fast-acting inexpensive and non-addictive opioid antagonist with minimal side effects Naloxone can be administered quickly and effectively by trained professional and lay individuals who observe the initial signs of an opioid overdose reactionrdquo
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
Naloxone Basics
21
Patients can go back into overdose if long acting opioids were taken
(fentanyl patch methadone extended release morphine extended release oxycodone)
Patients should avoid taking more opioids after naloxone administration so they do not go back into overdose after naloxone wears off
Patients may want to take more opioids during this time because they may feel withdrawal symptoms
Wears off in 30 - 90 minutes
Store at room temperature to minimize degradation
Shelf-life is 12-24 months
If patient is not responding in this time a second dose may need be administered
Takes effect in 2 - 3 minutes
21
Naloxone Formulations
Intranasal with atomizer attachment Auto-Injector
Intranasal spray Intramuscular injection
Rationale for Overdose Education
and Naloxone Rescue Kits bull Most people who use opioids do not use
alone
bull Known risk factors
Mixing substances loss of opioid
tolerance using alone unknown
source
bull Opportunity window
Opioid overdoses take minutes to hours
and is reversible with naloxone
Fentanyl reduces the window to seconds
to minutes
bull Bystanders are trainable to
recognize and respond to overdoses
bull Fear of public safety 23
Evaluations of Overdose Education and Naloxone Distribution Programs
24
Feasibility
bull Piper et al Subst Use Misuse 2008 43 858-70 bull Doe-Simkins et al Am J Public Health 2009 99 788-791 bull Enteen et al J Urban Health 201087 931-41 bull Bennett et al J Urban Health 2011 88 1020-30 bull Walley et al JSAT 2013 44241-7 (Methadone and detox programs)
Increased knowledge and skills
bull Green et al Addiction 2008 103979-89 bull Tobin et al Int J Drug Policy 2009 20 131-6 bull Wagner et al Int J Drug Policy 2010 21 186-93
No increase in use increase in drug
treatment
bull Seal et al J Urban Health 200582303-11 bull Doe-Simkins et al BMC Public Health 2014 14297 bull Jones et al Addictive Behaviors 201771104-6
Reduction in overdose in communities
bull Maxwell et al J Addict Dis 200625 89-96 bull Evans et al Am J Epidemiol 2012 174 302-8 bull Walley et al BMJ 2013 346 f174 bull Bird et al Addiction 2015 Dec 1 bull Coffin et al Ann Intern Med 2016 1-8
Cost-effective
$438 (best) to $14000 (worst ) per quality-
adjusted life year gained
bull Coffin and Sullivan Ann Intern Med 2013 Jan 1158(1)1-9
25
Objective Determine the impact of
opioid overdose education with
intranasal naloxone distribution
(OEND) programs on fatal and non-
fatal opioid overdose rates in
Massachusetts
Walley et al BMJ 2013 346 f174
INPEDE OD (Intranasal Naloxone and Prevention Educationrsquos Effect on
Overdose Study)
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
26
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
OEND programs 2006-07
27
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
28
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
29
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
Towns without
30
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
Fatal Opioid Overdose Rates by
OEND Implementation
31
Cumulative enrollments per 100k RR ARR 95 CI
Absolute model
No enrollment Ref Ref Ref
Low implementation 1-100 093 073 057-091
High implementation gt 100 082 054 039-076
Adjusted Rate Ratios (ARR) All rate ratios adjusted for the citytown
population rates of age under 18 male race ethnicity (hispanic white black other) below poverty level medically supervised
inpatient withdrawal treatment methadone treatment BSAS-funded buprenorphine treatment prescriptions to doctor shoppers and
year
Walley et al BMJ 2013 346 f174
Naloxone coverage per 100K
0
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
Opioid overdose death rate
27 reduction
32
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Naloxone Basics
21
Patients can go back into overdose if long acting opioids were taken
(fentanyl patch methadone extended release morphine extended release oxycodone)
Patients should avoid taking more opioids after naloxone administration so they do not go back into overdose after naloxone wears off
Patients may want to take more opioids during this time because they may feel withdrawal symptoms
Wears off in 30 - 90 minutes
Store at room temperature to minimize degradation
Shelf-life is 12-24 months
If patient is not responding in this time a second dose may need be administered
Takes effect in 2 - 3 minutes
21
Naloxone Formulations
Intranasal with atomizer attachment Auto-Injector
Intranasal spray Intramuscular injection
Rationale for Overdose Education
and Naloxone Rescue Kits bull Most people who use opioids do not use
alone
bull Known risk factors
Mixing substances loss of opioid
tolerance using alone unknown
source
bull Opportunity window
Opioid overdoses take minutes to hours
and is reversible with naloxone
Fentanyl reduces the window to seconds
to minutes
bull Bystanders are trainable to
recognize and respond to overdoses
bull Fear of public safety 23
Evaluations of Overdose Education and Naloxone Distribution Programs
24
Feasibility
bull Piper et al Subst Use Misuse 2008 43 858-70 bull Doe-Simkins et al Am J Public Health 2009 99 788-791 bull Enteen et al J Urban Health 201087 931-41 bull Bennett et al J Urban Health 2011 88 1020-30 bull Walley et al JSAT 2013 44241-7 (Methadone and detox programs)
Increased knowledge and skills
bull Green et al Addiction 2008 103979-89 bull Tobin et al Int J Drug Policy 2009 20 131-6 bull Wagner et al Int J Drug Policy 2010 21 186-93
No increase in use increase in drug
treatment
bull Seal et al J Urban Health 200582303-11 bull Doe-Simkins et al BMC Public Health 2014 14297 bull Jones et al Addictive Behaviors 201771104-6
Reduction in overdose in communities
bull Maxwell et al J Addict Dis 200625 89-96 bull Evans et al Am J Epidemiol 2012 174 302-8 bull Walley et al BMJ 2013 346 f174 bull Bird et al Addiction 2015 Dec 1 bull Coffin et al Ann Intern Med 2016 1-8
Cost-effective
$438 (best) to $14000 (worst ) per quality-
adjusted life year gained
bull Coffin and Sullivan Ann Intern Med 2013 Jan 1158(1)1-9
25
Objective Determine the impact of
opioid overdose education with
intranasal naloxone distribution
(OEND) programs on fatal and non-
fatal opioid overdose rates in
Massachusetts
Walley et al BMJ 2013 346 f174
INPEDE OD (Intranasal Naloxone and Prevention Educationrsquos Effect on
Overdose Study)
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
26
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
OEND programs 2006-07
27
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
28
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
29
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
Towns without
30
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
Fatal Opioid Overdose Rates by
OEND Implementation
31
Cumulative enrollments per 100k RR ARR 95 CI
Absolute model
No enrollment Ref Ref Ref
Low implementation 1-100 093 073 057-091
High implementation gt 100 082 054 039-076
Adjusted Rate Ratios (ARR) All rate ratios adjusted for the citytown
population rates of age under 18 male race ethnicity (hispanic white black other) below poverty level medically supervised
inpatient withdrawal treatment methadone treatment BSAS-funded buprenorphine treatment prescriptions to doctor shoppers and
year
Walley et al BMJ 2013 346 f174
Naloxone coverage per 100K
0
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
Opioid overdose death rate
27 reduction
32
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Naloxone Formulations
Intranasal with atomizer attachment Auto-Injector
Intranasal spray Intramuscular injection
Rationale for Overdose Education
and Naloxone Rescue Kits bull Most people who use opioids do not use
alone
bull Known risk factors
Mixing substances loss of opioid
tolerance using alone unknown
source
bull Opportunity window
Opioid overdoses take minutes to hours
and is reversible with naloxone
Fentanyl reduces the window to seconds
to minutes
bull Bystanders are trainable to
recognize and respond to overdoses
bull Fear of public safety 23
Evaluations of Overdose Education and Naloxone Distribution Programs
24
Feasibility
bull Piper et al Subst Use Misuse 2008 43 858-70 bull Doe-Simkins et al Am J Public Health 2009 99 788-791 bull Enteen et al J Urban Health 201087 931-41 bull Bennett et al J Urban Health 2011 88 1020-30 bull Walley et al JSAT 2013 44241-7 (Methadone and detox programs)
Increased knowledge and skills
bull Green et al Addiction 2008 103979-89 bull Tobin et al Int J Drug Policy 2009 20 131-6 bull Wagner et al Int J Drug Policy 2010 21 186-93
No increase in use increase in drug
treatment
bull Seal et al J Urban Health 200582303-11 bull Doe-Simkins et al BMC Public Health 2014 14297 bull Jones et al Addictive Behaviors 201771104-6
Reduction in overdose in communities
bull Maxwell et al J Addict Dis 200625 89-96 bull Evans et al Am J Epidemiol 2012 174 302-8 bull Walley et al BMJ 2013 346 f174 bull Bird et al Addiction 2015 Dec 1 bull Coffin et al Ann Intern Med 2016 1-8
Cost-effective
$438 (best) to $14000 (worst ) per quality-
adjusted life year gained
bull Coffin and Sullivan Ann Intern Med 2013 Jan 1158(1)1-9
25
Objective Determine the impact of
opioid overdose education with
intranasal naloxone distribution
(OEND) programs on fatal and non-
fatal opioid overdose rates in
Massachusetts
Walley et al BMJ 2013 346 f174
INPEDE OD (Intranasal Naloxone and Prevention Educationrsquos Effect on
Overdose Study)
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
26
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
OEND programs 2006-07
27
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
28
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
29
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
Towns without
30
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
Fatal Opioid Overdose Rates by
OEND Implementation
31
Cumulative enrollments per 100k RR ARR 95 CI
Absolute model
No enrollment Ref Ref Ref
Low implementation 1-100 093 073 057-091
High implementation gt 100 082 054 039-076
Adjusted Rate Ratios (ARR) All rate ratios adjusted for the citytown
population rates of age under 18 male race ethnicity (hispanic white black other) below poverty level medically supervised
inpatient withdrawal treatment methadone treatment BSAS-funded buprenorphine treatment prescriptions to doctor shoppers and
year
Walley et al BMJ 2013 346 f174
Naloxone coverage per 100K
0
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
Opioid overdose death rate
27 reduction
32
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Rationale for Overdose Education
and Naloxone Rescue Kits bull Most people who use opioids do not use
alone
bull Known risk factors
Mixing substances loss of opioid
tolerance using alone unknown
source
bull Opportunity window
Opioid overdoses take minutes to hours
and is reversible with naloxone
Fentanyl reduces the window to seconds
to minutes
bull Bystanders are trainable to
recognize and respond to overdoses
bull Fear of public safety 23
Evaluations of Overdose Education and Naloxone Distribution Programs
24
Feasibility
bull Piper et al Subst Use Misuse 2008 43 858-70 bull Doe-Simkins et al Am J Public Health 2009 99 788-791 bull Enteen et al J Urban Health 201087 931-41 bull Bennett et al J Urban Health 2011 88 1020-30 bull Walley et al JSAT 2013 44241-7 (Methadone and detox programs)
Increased knowledge and skills
bull Green et al Addiction 2008 103979-89 bull Tobin et al Int J Drug Policy 2009 20 131-6 bull Wagner et al Int J Drug Policy 2010 21 186-93
No increase in use increase in drug
treatment
bull Seal et al J Urban Health 200582303-11 bull Doe-Simkins et al BMC Public Health 2014 14297 bull Jones et al Addictive Behaviors 201771104-6
Reduction in overdose in communities
bull Maxwell et al J Addict Dis 200625 89-96 bull Evans et al Am J Epidemiol 2012 174 302-8 bull Walley et al BMJ 2013 346 f174 bull Bird et al Addiction 2015 Dec 1 bull Coffin et al Ann Intern Med 2016 1-8
Cost-effective
$438 (best) to $14000 (worst ) per quality-
adjusted life year gained
bull Coffin and Sullivan Ann Intern Med 2013 Jan 1158(1)1-9
25
Objective Determine the impact of
opioid overdose education with
intranasal naloxone distribution
(OEND) programs on fatal and non-
fatal opioid overdose rates in
Massachusetts
Walley et al BMJ 2013 346 f174
INPEDE OD (Intranasal Naloxone and Prevention Educationrsquos Effect on
Overdose Study)
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
26
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
OEND programs 2006-07
27
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
28
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
29
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
Towns without
30
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
Fatal Opioid Overdose Rates by
OEND Implementation
31
Cumulative enrollments per 100k RR ARR 95 CI
Absolute model
No enrollment Ref Ref Ref
Low implementation 1-100 093 073 057-091
High implementation gt 100 082 054 039-076
Adjusted Rate Ratios (ARR) All rate ratios adjusted for the citytown
population rates of age under 18 male race ethnicity (hispanic white black other) below poverty level medically supervised
inpatient withdrawal treatment methadone treatment BSAS-funded buprenorphine treatment prescriptions to doctor shoppers and
year
Walley et al BMJ 2013 346 f174
Naloxone coverage per 100K
0
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
Opioid overdose death rate
27 reduction
32
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Evaluations of Overdose Education and Naloxone Distribution Programs
24
Feasibility
bull Piper et al Subst Use Misuse 2008 43 858-70 bull Doe-Simkins et al Am J Public Health 2009 99 788-791 bull Enteen et al J Urban Health 201087 931-41 bull Bennett et al J Urban Health 2011 88 1020-30 bull Walley et al JSAT 2013 44241-7 (Methadone and detox programs)
Increased knowledge and skills
bull Green et al Addiction 2008 103979-89 bull Tobin et al Int J Drug Policy 2009 20 131-6 bull Wagner et al Int J Drug Policy 2010 21 186-93
No increase in use increase in drug
treatment
bull Seal et al J Urban Health 200582303-11 bull Doe-Simkins et al BMC Public Health 2014 14297 bull Jones et al Addictive Behaviors 201771104-6
Reduction in overdose in communities
bull Maxwell et al J Addict Dis 200625 89-96 bull Evans et al Am J Epidemiol 2012 174 302-8 bull Walley et al BMJ 2013 346 f174 bull Bird et al Addiction 2015 Dec 1 bull Coffin et al Ann Intern Med 2016 1-8
Cost-effective
$438 (best) to $14000 (worst ) per quality-
adjusted life year gained
bull Coffin and Sullivan Ann Intern Med 2013 Jan 1158(1)1-9
25
Objective Determine the impact of
opioid overdose education with
intranasal naloxone distribution
(OEND) programs on fatal and non-
fatal opioid overdose rates in
Massachusetts
Walley et al BMJ 2013 346 f174
INPEDE OD (Intranasal Naloxone and Prevention Educationrsquos Effect on
Overdose Study)
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
26
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
OEND programs 2006-07
27
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
28
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
29
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
Towns without
30
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
Fatal Opioid Overdose Rates by
OEND Implementation
31
Cumulative enrollments per 100k RR ARR 95 CI
Absolute model
No enrollment Ref Ref Ref
Low implementation 1-100 093 073 057-091
High implementation gt 100 082 054 039-076
Adjusted Rate Ratios (ARR) All rate ratios adjusted for the citytown
population rates of age under 18 male race ethnicity (hispanic white black other) below poverty level medically supervised
inpatient withdrawal treatment methadone treatment BSAS-funded buprenorphine treatment prescriptions to doctor shoppers and
year
Walley et al BMJ 2013 346 f174
Naloxone coverage per 100K
0
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
Opioid overdose death rate
27 reduction
32
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
25
Objective Determine the impact of
opioid overdose education with
intranasal naloxone distribution
(OEND) programs on fatal and non-
fatal opioid overdose rates in
Massachusetts
Walley et al BMJ 2013 346 f174
INPEDE OD (Intranasal Naloxone and Prevention Educationrsquos Effect on
Overdose Study)
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
26
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
OEND programs 2006-07
27
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
28
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
29
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
Towns without
30
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
Fatal Opioid Overdose Rates by
OEND Implementation
31
Cumulative enrollments per 100k RR ARR 95 CI
Absolute model
No enrollment Ref Ref Ref
Low implementation 1-100 093 073 057-091
High implementation gt 100 082 054 039-076
Adjusted Rate Ratios (ARR) All rate ratios adjusted for the citytown
population rates of age under 18 male race ethnicity (hispanic white black other) below poverty level medically supervised
inpatient withdrawal treatment methadone treatment BSAS-funded buprenorphine treatment prescriptions to doctor shoppers and
year
Walley et al BMJ 2013 346 f174
Naloxone coverage per 100K
0
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
Opioid overdose death rate
27 reduction
32
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
26
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
OEND programs 2006-07
27
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
28
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
29
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
Towns without
30
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
Fatal Opioid Overdose Rates by
OEND Implementation
31
Cumulative enrollments per 100k RR ARR 95 CI
Absolute model
No enrollment Ref Ref Ref
Low implementation 1-100 093 073 057-091
High implementation gt 100 082 054 039-076
Adjusted Rate Ratios (ARR) All rate ratios adjusted for the citytown
population rates of age under 18 male race ethnicity (hispanic white black other) below poverty level medically supervised
inpatient withdrawal treatment methadone treatment BSAS-funded buprenorphine treatment prescriptions to doctor shoppers and
year
Walley et al BMJ 2013 346 f174
Naloxone coverage per 100K
0
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
Opioid overdose death rate
27 reduction
32
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
OEND programs 2006-07
27
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
28
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
29
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
Towns without
30
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
Fatal Opioid Overdose Rates by
OEND Implementation
31
Cumulative enrollments per 100k RR ARR 95 CI
Absolute model
No enrollment Ref Ref Ref
Low implementation 1-100 093 073 057-091
High implementation gt 100 082 054 039-076
Adjusted Rate Ratios (ARR) All rate ratios adjusted for the citytown
population rates of age under 18 male race ethnicity (hispanic white black other) below poverty level medically supervised
inpatient withdrawal treatment methadone treatment BSAS-funded buprenorphine treatment prescriptions to doctor shoppers and
year
Walley et al BMJ 2013 346 f174
Naloxone coverage per 100K
0
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
Opioid overdose death rate
27 reduction
32
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
OEND programs 2006-07
2007-08
28
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
29
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
Towns without
30
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
Fatal Opioid Overdose Rates by
OEND Implementation
31
Cumulative enrollments per 100k RR ARR 95 CI
Absolute model
No enrollment Ref Ref Ref
Low implementation 1-100 093 073 057-091
High implementation gt 100 082 054 039-076
Adjusted Rate Ratios (ARR) All rate ratios adjusted for the citytown
population rates of age under 18 male race ethnicity (hispanic white black other) below poverty level medically supervised
inpatient withdrawal treatment methadone treatment BSAS-funded buprenorphine treatment prescriptions to doctor shoppers and
year
Walley et al BMJ 2013 346 f174
Naloxone coverage per 100K
0
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
Opioid overdose death rate
27 reduction
32
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
OEND programs 2006-07
2007-08
2009
29
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
OEND programs 2006-07
2007-08
2009
Towns without
30
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
Fatal Opioid Overdose Rates by
OEND Implementation
31
Cumulative enrollments per 100k RR ARR 95 CI
Absolute model
No enrollment Ref Ref Ref
Low implementation 1-100 093 073 057-091
High implementation gt 100 082 054 039-076
Adjusted Rate Ratios (ARR) All rate ratios adjusted for the citytown
population rates of age under 18 male race ethnicity (hispanic white black other) below poverty level medically supervised
inpatient withdrawal treatment methadone treatment BSAS-funded buprenorphine treatment prescriptions to doctor shoppers and
year
Walley et al BMJ 2013 346 f174
Naloxone coverage per 100K
0
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
Opioid overdose death rate
27 reduction
32
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
OEND programs 2006-07
2007-08
2009
Towns without
30
Number of Deaths
No Deaths
1 ndash 5
6 - 15
16 - 30
30+
Opioid Overdose Related Deaths
Massachusetts 2004 - 2006
Fatal Opioid Overdose Rates by
OEND Implementation
31
Cumulative enrollments per 100k RR ARR 95 CI
Absolute model
No enrollment Ref Ref Ref
Low implementation 1-100 093 073 057-091
High implementation gt 100 082 054 039-076
Adjusted Rate Ratios (ARR) All rate ratios adjusted for the citytown
population rates of age under 18 male race ethnicity (hispanic white black other) below poverty level medically supervised
inpatient withdrawal treatment methadone treatment BSAS-funded buprenorphine treatment prescriptions to doctor shoppers and
year
Walley et al BMJ 2013 346 f174
Naloxone coverage per 100K
0
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
Opioid overdose death rate
27 reduction
32
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Fatal Opioid Overdose Rates by
OEND Implementation
31
Cumulative enrollments per 100k RR ARR 95 CI
Absolute model
No enrollment Ref Ref Ref
Low implementation 1-100 093 073 057-091
High implementation gt 100 082 054 039-076
Adjusted Rate Ratios (ARR) All rate ratios adjusted for the citytown
population rates of age under 18 male race ethnicity (hispanic white black other) below poverty level medically supervised
inpatient withdrawal treatment methadone treatment BSAS-funded buprenorphine treatment prescriptions to doctor shoppers and
year
Walley et al BMJ 2013 346 f174
Naloxone coverage per 100K
0
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
Opioid overdose death rate
27 reduction
32
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Naloxone coverage per 100K
0
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
Opioid overdose death rate
27 reduction
32
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Naloxone coverage per 100K
0
Opioid overdose death rate
250 100
90
200 80
70
150 60
50
100
50
40
30
20
10
0
No coverage
1-100 ppl
100+ ppl
46 reduction
33
Walley et al BMJ 2013 346 f174
Fatal Opioid Overdose Rates by
OEND Implementation
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Wheeler E et al Morb Mortal Wkly Rep 201564631-635
Community Naloxone Programs 2014
34
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Implementing Overdose Prevention in
Addiction Treatment Settings
35
Model Advantages Disadvantages
bull Staff provide OEND
on-site
bull Good access to OEND
bull Opioid overdose prevention
integrated
bull Patients may not
disclose risk
bull Outside staff provide
OEND on-site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Low burden on staff
bull Community OEND
program needed
bull OE provided onsite
naloxone received off-
site
bull Opioid overdose prevention integrated
bull Interagency cooperation
bull Increased patient burden
to get naloxone
bull Outside staff recruit
near methadone
maintenance treatment
(MMT) or detoxification
bull Confidential access to opioid overdose prevention
bull Opioid overdose prevention not re-
enforced in treatment
bull Not all patients reached
Donrsquot forget the staff Among 29 MMT and 93 detoxification staff who received OEND 38 and
45 respectively reported witnessing an overdose in their lifetime
Walley et al JSAT 2013 44241-7
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Other Venues and Models
36
bull Buprenorphine and naltrexone treatment
bull First responder ndash police and fire
bull Emergency Department (ED) SBIRT
bull Post-incarceration
bull Prescription naloxone
Prescribetopreventorg
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Overdose Prevention for Patients
37
bull Review medications ndash Communicate with other prescribers
bull Take a substance use history
bull Check the prescription monitoring program
Overdose history Ask your patients
How do you protect yourself against overdose
How do you keep your medications safe at home
And their loved ones
What is your plan if you witness an overdose in the future
Have you received training to prevent recognize or respond to an
overdose
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
What they need to know
bull Prevention - the risks Mixing substances
Abstinence- low tolerance
Using alone
Unknown source
Chronic medical disease
Long acting opioids last longer
bull Recognition Unresponsive to sternal rub with slowed or
absent breathing
Blue lips pinpoint pupils
bull Response - What to do Call for help
Rescue breathe
Deliver naloxone and wait 3 minutes
Stay until help arrives
Patient education videos and
materials at
prescribetopreventorg
38
Overdose Prevention for Patients
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Rescue breathe chest compressions per rescuerrsquos level of training
3 4
How to Respond in an Overdose
Steps to teach patients family friends caregivers
Recognize overdose
Call 911 for help
Administer naloxone as soon as it is available
Stay until help arrives Place in recovery
position if breathing
5
1
2
Multi-step nasal
spray
Single-step nasal spray
(NARCANreg)
Intramuscular injection
Auto-injector (EVZIOreg)
39
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
American Heart Association Guidelines October 2015
httpseccguidelinesheartorgwp-contentuploads2015102015-AHA-Guidelines-
Highlights-Englishpdf
Updated Opioid
Associated Life
Threatening
Emergency
(ADULT) Algorithm
40
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
bull Objective To evaluate the feasibility and effect of implementing naloxone
prescription to patients prescribed opioids for chronic pain at 6 safety-net primary
care clinics
bull Results
38 of 1985 patients receiving long term opioids co-prescribed naloxone
rescue kits
Patients with higher opioid doses and previous opioid-related ED visits were
more likely to be prescribed naloxone kits
Opioid-related ED visits were reduced by 47 at 6 months and 63 at 12
months among those who were co-prescribed naloxone compared with those
who were not
No change was detected in the net prescribed opioid doses for patients who
were co-prescribed naloxone
41 Coffin PO et al Nonrandomized intervention study of naloxone
coprescription for primary care patient receiving long-term opioid therapy
for pain Ann Intern Med 2016 1-8
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Innovations Models for
Pharmacy Naloxone
Setting clinic with insured patients
Informational brochure patient fills
Pharmacies alerted to prescribing plans
May need to have atomizers on-site if intranasal formulation
Prescriber writes prescription
Patient fills at pharmacy
Without prescriber contact under a standing order
Pharmacy provides naloxone directly to customer
Training needed Passive or active models Naloxone co-prescription Universal offer may require clear policy direction
Without prescriber or pharmacy contact under a standing order distribution model
Pharmacy provides naloxone to patients in treatment
centerclinic
Patient training done on-site at clinic facilitates facility-level compliance and sustainability
42
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Offer Naloxone to Everyonehellip
bull Any opioid prescription
bull Any opioidbenzodiazepine rx combination
bull Any diseaseopioid combination
bull Any methadone
bull Any buprenorphine
bull Any naltrexone for opioids
bull Transitions of care
bull Friends and family of those at risk
bull Syringe buyer request
bull Addiction treatment
bull Correctional institution
bull Behavioral health
43
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Practical Barriers to Prescribing Naloxone
44
1 Prescriber knowledge and comfort
2 How to write the prescription
3 Does the pharmacy stock rescue kits
bull Work with your pharmacy to get it stocked
4 Who pays for it
bull Work with your pharmacy to see if they will
cover it
bull Advocate with insurance (eg Medicaid) to
get naloxone on formulary
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Legal Barriers to Prescription Model
45
ldquoPrescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing The risks of malpractice liability are consistent with those generally associated with providing healthcare and can be further minimized by following simple guidelines presented
bull Only prescribe to a person who is at risk for overdose
bull Ensure that the patient is properly instructed in the
administration and risks of naloxone
Does your state permit prescribing to people NOT at risk of overdose
Does your state have a Good Samaritan law
bull Go to pdapsorg ndash to find out
Burris S at al ldquoLegal aspects of providing naloxone to heroin users
in the United States Int J of Drug Policy 2001 12 237-248
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Example of Overdose-Naloxone Law
Good Samaritan limited liability for patientsprescibers and 3rd party prescribing
Enforcement Tools 46
Good Samaritan provision
bull Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession
Protection does not extend to trafficking or distribution charges
Patient protection
bull A person acting in good faith may receive a naloxone prescription possess naloxone and administer naloxone to an individual appearing to experience an opioid-related overdose
Prescriber protection
bull Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opioid-related overdose or a family member friend or other person in a position to assist a person at risk of experiencing an opioid-related overdose For purposes of this chapter and chapter 112 any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice
Massachusetts - Passed in August 2012
An Act Relative to Sentencing and Improving Law
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Case 29 yo woman presents to
clinic for buprenorphine treatment
47
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Case 29 yo woman presents to
clinic for buprenorphine treatment
48
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Case 29 yo woman presents to
clinic for buprenorphine treatment
49
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Case 29 yo woman presents to
clinic for buprenorphine treatment
50
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Case 29 yo woman presents to
clinic for buprenorphine treatment
51
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Case 29 yo woman presents to
clinic for buprenorphine treatment
52
bull Age 18 an accomplished athlete with collegiate prospects
When she tore her ACL she was prescribed opioids after surgery
Developed an opioid use disorder by 6 months
Age 20 injection heroin daily out of college
bull Ages 20-26 multiple detoxification and residential programs
Not able to sustain gt3 months without relapse
bull Age 26 pregnant at her last detoxification and transferred to methadone
Able to stop using heroin engage in 12-step
Delivered a healthy baby breastfed retained custody
bull Age 28 she tapered off of methadone
Wanted more time with the baby and to work
Boyfriend incarcerated for selling drugs
Relapsed lost custody now seeking treatment with buprenorphine
Does not want to go to the methadone clinic every day
Received a new naloxone kit from needle exchange
Started tester shots respecting her tolerance at each relapse - Rescued boyfriend x2
Overdose prevention education during orientation
Overdose prevention education and rescue kit part of her taper and discharge plan
Counseled about the risks of overdose addiction and safe storage
Prescribed naloxone rescue kit when prescribed opioids for pain
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Case 29 yo woman on
buprenorphine treatment
53
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
Case 29 yo woman on
buprenorphine treatment
54
Overdose prevention education and naloxone kit part of her orientation
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Case 29 yo woman on
buprenorphine treatment
55
Regular clinic visits with urine tox only positive for buprenorphine Overdose prevention education and naloxone kit part of her orientation
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Case 29 yo woman on
buprenorphine treatment
56
And she lived happily ever after
bull Age 29-30 Good response to office-based buprenorphine treatment
Regular clinic visits with urine tox only positive for buprenorphine
Re-engages in 12-step program and with her family
Works with child protection to regain custody
bull Age 30 Continues in her recovery despite BFrsquos relapse and overdose
Her boyfriend had been released from jail and returned to stay with her
He relapsed and overdose on heroin on the 3rd night
minus She called 911 started rescue breathing and administered one
dose of nasal naloxone He was transported observed and
transferred to a residential program for formerly incarcerated with
drug problems
minus Police and EMS praised her for her response ldquoIt saved his liferdquo
She called her buprenorphine program counselor and went to
group counseling that week where she received support
Overdose prevention education and naloxone kit part of her orientation
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Helpful Websites
57
bull For prescribers and pharmacists
Prescribetopreventorg
bull News + research on overdose prevention
Overdosepreventionallianceorg
bull International overdose prevention efforts
Naloxoneinfoorg
bull Opioid overdose prevention education
Stopoverdoseorg
bull Family support
Learn2Copecom
httppdapsorg
bull Project manual
harmreductionorgwp-
contentuploads201211od-
manual-final-linkspdf
bull 2013 National Drug Control Strategy
wwwwhitehousegovondcp2013-
national-drug-control-strategy
bull ASAM 2010 Policy Statement
wwwasamorgdocspublicy-policy-
statements1naloxone-1-10pdf
bull SAMHSA Toolkit
httpsstoresamhsagovproductO
pioid-Overdose-Prevention-
ToolkitSMA16-4742
bull SAMHSA Letter to prescribers
wwwdptsamhsagovpdfdearCollea
gueSAMHSA_fen tanyl_508pdf
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
References
58
bull Alford DP Zisblatt L Ng P Hayes SM Peloquin S Hardesty I White JL SCOPE of pain an evaluation of an opioid risk
evaluation and mitigation strategy continuing education program Pain Medicine 2016 Jan 117(1)52-63
bull Alpert A Powell D Pacula RL Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of
Abuse-Deterrent Opioids National Bureau of Economic Research 2017 Jan 5
bull American Heart Association Guidelines October 2015 httpseccguidelinesheartorgwp-contentuploads2015102015-
AHA-Guidelines-Highlights-Englishpdf
bull Bennett et al 2011 Characteristics of an overdose prevention response and naloxone distribution program in Pittsburgh
and Allegheny County Pennsylvania J Urban Health 881020-30
bull Bird SM12 McAuley A34 Perry S5 Hunter C6 Addiction 2016 May111(5)883-91 doi 101111add13265 Epub 2016 Feb
4 Effectiveness of Scotlands National Naloxone Programme for reducing opioid-related deaths a before (2006-10) versus
after (2011-13) comparison
bull Boscarino JA1 Kirchner HL2 Pitcavage JM1 Nadipelli VR3 Ronquest NA3 Fitzpatrick MH4 Han JJ5 Subst Abuse
Rehabil 2016 Sep 167131-141 eCollection 2016
bull Factors associated with opioid overdose a 10-year retrospective study of patients in a large integrated health care system
bull Florence CS1 Zhou C Luo F Xu L Med Care 2016 Oct54(10)901-6 doi 101097MLR0000000000000625
bull The Economic Burden of Prescription Opioid Overdose Abuse and Dependence in the United States 2013
bull Burris S at al 2011 Legal aspects of providing naloxone to heroin users in the United States Int J of Drug Policy 12237-
248
bull Clausen et al 2009 Mortality among opiate users opioid maintenance therapy age and causes of death Addiction 1041356-
62
bull Coffin and Sullivan 2013 Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal Ann Intern
Med 1581-9
bull Doe-Simkins et al 2009 Saved by the nose bystander-administered intranasal naloxone hydrochloride for opioid overdose
Am J Public Health 99 788-791
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
References
59
bull
bull Doe-Simkins M et al 2014 Overdose rescued by trained and untrained participants and change in opioid use among
substance-using participants in overdose education and naloxone distribution programs a retrospective cohort study BMC
Public Health 14297
bull Enteen et al 2010 Overdose prevention and naloxone prescription for opioid users in San Francisco J Urban Health 87931-
41
bull Evans et al 2012 Mortality among young injection drug users in San Francisco a 10-year follow-up of the UFO study Am J
Epidemiol 174302-8
bull Gray and Hagemeir 2012 Prescription drug abuse and DEA-sanctioned drug take-back events characteristics and outcomes
in rural Appalachia JAMA intern Med 721186-7
bull Green et al 2008 Distringuishing signs of opioid overdose and indication for naloxone an evaluation of six overdose training
and naloxone distribution programs in the United States Addiction 103979-89
bull Inocencio TJ et al 2013 The economic burden of opioid-related poisoning in the United States Pain Medicine 141534-47
bull Katz J The First Count of Fentanyl Deaths in 2016 Up 540 in Three Years NYT ndash The UpShot 922017
bull McAuley A1 Aucott L2 Matheson C2 nt J Drug Policy 2015 Dec26(12)1183-8 doi 101016jdrugpo201509011 Epub
2015 Oct 1 Exploring the life-saving potential of naloxone A systematic review and descriptive meta-analysis of take home
naloxone (THN) programmes for opioid users
bull Marshall et Al 2011 Reduction in overdose mortality after the opening of North Americas first medically supervised safer
injecting facility a retrospective population-based study Lancet 3771429-37
bull Maxwell et al 2006 Prescribing naloxone to actively injecting heroin users a program to reduce heroin overdose deaths J
Addict Dis 2589-96
bull Rudd RA Seth P David F Scholl L MMWR Morb Mortal Wkly Rep 2016 Dec 3065(5051)1445-1452 doi
1015585mmwrmm655051e1 Increases in Drug and Opioid-Involved Overdose Deaths - United States 2010-2015
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
References
60
bull Patrick SW1 Fry CE2 Jones TF3 Buntin MB4 Health Aff (Millwood) 2016 Jul 135(7)1324-32 doi101377hlthaff20151496
Epub 2016 Jun 22 Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-
Related Death Rates
bull Paulozzi et al 2011 Prescription drug monitoring programs and death rates from drug overdose Pain Medicine 12747-54
bull Piper et al 2008 Evaluation of a naloxone distribution and administration program in New York City Subst Use Misuse 43858-
70
bull Seal et al 2005 Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin
overdose death a pilot intervention study J Urban Health 82303-11
bull Tobin et al 2009 Evaluation of the Staying Alive programmed training injection drug users to properly administer naloxone and
save lives Int J Drug Policy 20131-6
bull Wagner et al 2010 Evaluation of an overdose prevention and response training programmed for injection drug users in the Skid
Row area of Los AngelesCA Int J Drug Policy 21186-93
bull Walley et al 2013 Opioid overdose prevention with intranasal naloxone among people who take methadone JSAT 44241-7
Walley et al 2013 Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in
Massachusetts interrupted time series analysis BMJ 346f174
bull Wheeler E et al 2012 Community-based opioid overdose prevention programs providing naloxone - United States 2010Morb
Mortal Wkly Rep 61101-5
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
PCSS Mentor Program
bull PCSS Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
bull PCSS mentors are a national network of providers with expertise in
addictions pain evidence-based treatment including medication-
assisted treatment
bull 3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
bull No cost
For more information visit
pcssNOWorgclinical-coaching
61
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
PCSS Discussion Forum
Have a clinical question
62
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects
Funding for this initiative was made possible (in part) by grant nos 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA The
views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the
official policies of the Department of Health and Human Services nor does mention of trade names commercial practices or
organizations imply endorsement by the US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Neurology (AAN) American Academy of Pain Medicine (AAPM)
American Academy of Pediatrics (AAP) American College of Emergency Physicians (ACEP) American
College of Physicians (ACP) American Dental Association (ADA) American Medical Association (AMA)
American Osteopathic Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA)
American Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM)
American Society for Pain Management Nursing (ASPMN) Association for Medical Education and
Research in Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) National Association of Drug Court Professionals
(NADCP) and the Southeast Consortium for Substance Abuse Training (SECSAT)
For more information wwwpcssNOWorg
PCSSProjects
wwwfacebookcompcssprojects